reference_id,authors,title,journal,year,volume,citation_footer,citation_type,citation,urls,pubmed_id,doi,header,reference_type,study_id,exclusion_reason
CD006468-bib-0001,"Bern MM, Lokich JJ, Wallach SR, Bothe A, Benotti PN, Arkin CF, et al. ",Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial, Annals of Internal Medicine ,1990,112,    ,['citation-journal']," Bern MM, Lokich JJ, Wallach SR, Bothe A, Benotti PN, Arkin CF, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial.  Annals of Internal Medicine 1990;112(6):423‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.7326/0003-4819-76-3-112-6-423', 'https://www.ncbi.nlm.nih.gov/pubmed/2178534', 'https://scholar.google.com/scholar_lookup?title=Very+low+doses+of+warfarin+can+prevent+thrombosis+in+central+venous+catheters.+A+randomized+prospective+trial+&author=MM+Bern&author=JJ+Lokich&author=SR+Wallach&author=A+Bothe&author=PN+Benotti&author=CF+Arkin&publication_year=1990&hl=en']",2178534,https://doi.org/10.7326/0003-4819-76-3-112-6-423, Bern 1990 {published data only}  ,included,CD006468-bbs2-0001,
CD006468-bib-0002,"Bern MM, Lokich JJ, Wallach SR, Huberman M, Tangen O. ",Very low‐dose warfarin prevents thrombosis in central vein catheters, ASCO Annual Meeting Proceedings ,1986,5,    ,['citation-journal']," Bern MM, Lokich JJ, Wallach SR, Huberman M, Tangen O. Very low‐dose warfarin prevents thrombosis in central vein catheters.  ASCO Annual Meeting Proceedings 1986;5:254. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Very+low‐dose+warfarin+prevents+thrombosis+in+central+vein+catheters&author=MM+Bern&author=JJ+Lokich&author=SR+Wallach&author=M+Huberman&author=O+Tangen&publication_year=1986&hl=en']",,, Bern 1990 {published data only}  ,included,CD006468-bbs2-0001,
CD006468-bib-0003,"Anderson D, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, et al. ",A randomized double‐blind placebo controlled study of low dose warfarin for the prevention of symptomatic central venous catheter‐associated thrombosis in patients with cancer, Journal of thrombosis and haemostasis : JTH ,2003,,    ,['citation-journal']," Anderson D, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, et al. A randomized double‐blind placebo controlled study of low dose warfarin for the prevention of symptomatic central venous catheter‐associated thrombosis in patients with cancer.  Journal of thrombosis and haemostasis : JTH 2003:P198. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/j.1538-7836.2003.tb05632.x', 'https://scholar.google.com/scholar_lookup?title=A+randomized+double‐blind+placebo+controlled+study+of+low+dose+warfarin+for+the+prevention+of+symptomatic+central+venous+catheter‐associated+thrombosis+in+patients+with+cancer+&author=D+Anderson&author=M+Goodyear&author=M+Burnell&author=S+Dolan&author=P+Wasi&author=D+Barnes&publication_year=2003&hl=en']",,https://doi.org/10.1111/j.1538-7836.2003.tb05632.x, Couban 2005 {published data only}  ,included,CD006468-bbs2-0002,
CD006468-bib-0004,"Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, et al. ",Randomized placebo‐controlled study of low‐dose warfarin for the prevention of central venous catheter‐associated thrombosis in patients with cancer, Journal of Clinical Oncology ,2005,23,    ,['citation-journal']," Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, et al. Randomized placebo‐controlled study of low‐dose warfarin for the prevention of central venous catheter‐associated thrombosis in patients with cancer.  Journal of Clinical Oncology 2005;23(18):4063‐9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1200/JCO.2005.10.192', 'https://www.ncbi.nlm.nih.gov/pubmed/15767639', 'https://scholar.google.com/scholar_lookup?title=Randomized+placebo‐controlled+study+of+low‐dose+warfarin+for+the+prevention+of+central+venous+catheter‐associated+thrombosis+in+patients+with+cancer+&author=S+Couban&author=M+Goodyear&author=M+Burnell&author=S+Dolan&author=P+Wasi&author=D+Barnes&publication_year=2005&hl=en']",15767639,https://doi.org/10.1200/JCO.2005.10.192, Couban 2005 {published data only}  ,included,CD006468-bbs2-0002,
CD006468-bib-0005,"Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Macleod D, et al. ",A randomized double‐blind placebo‐controlled study of low dose warfarin for the prevention of symptomatic central venous catheter‐associated thrombosis in patients with cancer," Blood, American Society of Hematology 44th Annual Meeting ",2002,100,    ,['citation-journal']," Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Macleod D, et al. A randomized double‐blind placebo‐controlled study of low dose warfarin for the prevention of symptomatic central venous catheter‐associated thrombosis in patients with cancer.  Blood, American Society of Hematology 44th Annual Meeting 2002;100(11):703. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+randomized+double‐blind+placebo‐controlled+study+of+low+dose+warfarin+for+the+prevention+of+symptomatic+central+venous+catheter‐associated+thrombosis+in+patients+with+cancer+&author=S+Couban&author=M+Goodyear&author=M+Burnell&author=S+Dolan&author=P+Wasi&author=D+Macleod&publication_year=2002&hl=en']",,, Couban 2005 {published data only}  ,included,CD006468-bbs2-0002,
CD006468-bib-0006,"De Cicco M, Matovic M, Balestreri L, Steffan A, Pacenzia R, Malafronte M, et al. ",Early and short‐term acenocumarine or dalteparin for the prevention of central vein catheter‐related thrombosis in cancer patients: a randomized controlled study based on serial venographies, Annals of Oncology ,2009,20,    ,['citation-journal']," De Cicco M, Matovic M, Balestreri L, Steffan A, Pacenzia R, Malafronte M, et al. Early and short‐term acenocumarine or dalteparin for the prevention of central vein catheter‐related thrombosis in cancer patients: a randomized controlled study based on serial venographies.  Annals of Oncology 2009;20(12):1936‐42. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1093/annonc/mdp235', 'https://www.ncbi.nlm.nih.gov/pubmed/19567452', 'https://scholar.google.com/scholar_lookup?title=Early+and+short‐term+acenocumarine+or+dalteparin+for+the+prevention+of+central+vein+catheter‐related+thrombosis+in+cancer+patients:+a+randomized+controlled+study+based+on+serial+venographies+&author=M+Cicco&author=M+Matovic&author=L+Balestreri&author=A+Steffan&author=R+Pacenzia&author=M+Malafronte&publication_year=2009&hl=en']",19567452,https://doi.org/10.1093/annonc/mdp235, De Cicco 2009 {published data only}  ,included,CD006468-bbs2-0003,
CD006468-bib-0007,"De Cicco M, Matovic M, Pacenzia R, Fantin D, Caserta M, Bortolussi R, et al. ",Short‐term acenocumarine (A) or dalteparine (D) for the prevention of central venous catheter‐related thrombosis (CVCrT) in cancer patients. A randomized controlled study based on serial venographies, Journal of Clinical Oncology ,2006,24 Suppl,    ,['citation-journal']," De Cicco M, Matovic M, Pacenzia R, Fantin D, Caserta M, Bortolussi R, et al. Short‐term acenocumarine (A) or dalteparine (D) for the prevention of central venous catheter‐related thrombosis (CVCrT) in cancer patients. A randomized controlled study based on serial venographies.  Journal of Clinical Oncology 2006;24 Suppl:18. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1200/jco.2006.24.18_suppl.8549', 'https://scholar.google.com/scholar_lookup?title=Short‐term+acenocumarine+(A)+or+dalteparine+(D)+for+the+prevention+of+central+venous+catheter‐related+thrombosis+(CVCrT)+in+cancer+patients.+A+randomized+controlled+study+based+on+serial+venographies+&author=M+Cicco&author=M+Matovic&author=R+Pacenzia&author=D+Fantin&author=M+Caserta&author=R+Bortolussi&publication_year=2006&hl=en']",,https://doi.org/10.1200/jco.2006.24.18_suppl.8549, De Cicco 2009 {published data only}  ,included,CD006468-bbs2-0003,
CD006468-bib-0008,"Heaton DC, Hyan DY, Inder A. ",Minidose (1mg) warfarin as prophylaxis for central vein catheter thrombosis, Internal Medicine Journal ,2002,32,    ,['citation-journal']," Heaton DC, Hyan DY, Inder A. Minidose (1mg) warfarin as prophylaxis for central vein catheter thrombosis.  Internal Medicine Journal 2002;32:84‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1046/j.1445-5994.2002.00171.x', 'https://www.ncbi.nlm.nih.gov/pubmed/11885848', 'https://scholar.google.com/scholar_lookup?title=Minidose+(1mg)+warfarin+as+prophylaxis+for+central+vein+catheter+thrombosis&author=DC+Heaton&author=DY+Hyan&author=A+Inder&publication_year=2002&hl=en']",11885848,https://doi.org/10.1046/j.1445-5994.2002.00171.x, Heaton 2002 {published data only}  ,included,CD006468-bbs2-0004,
CD006468-bib-0009,"Karthaus M, Kretzschmar A, Kroning H, Biakhov M, Irwin D, Marschner N, et al. ","Dalteparin for prevention of catheter‐related complications in cancer patients with central venous catheters: final results of a double‐blind, placebo‐controlled phase III trial", Annals of Oncology ,2006,17,    ,['citation-journal']," Karthaus M, Kretzschmar A, Kroning H, Biakhov M, Irwin D, Marschner N, et al. Dalteparin for prevention of catheter‐related complications in cancer patients with central venous catheters: final results of a double‐blind, placebo‐controlled phase III trial.  Annals of Oncology 2006;17(2):289‐96. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1093/annonc/mdj059', 'https://www.ncbi.nlm.nih.gov/pubmed/16317012', 'https://scholar.google.com/scholar_lookup?title=Dalteparin+for+prevention+of+catheter‐related+complications+in+cancer+patients+with+central+venous+catheters:+final+results+of+a+double‐blind,+placebo‐controlled+phase+III+trial+&author=M+Karthaus&author=A+Kretzschmar&author=H+Kroning&author=M+Biakhov&author=D+Irwin&author=N+Marschner&publication_year=2006&hl=en']",16317012,https://doi.org/10.1093/annonc/mdj059, Karthaus 2006 {published data only}  ,included,CD006468-bbs2-0005,
CD006468-bib-0010,"Reichardt P, Kretzschmar A, Biakhov M, Irwin D, Slabber C, Miller L, et al. ","A phase III randomized, double‐blind, placebo‐controlled study evaluating the efficacy and safety of daily low‐molecular‐weight heparin (dalteparin sodium, Fragmin) in preventing catheter‐related complications (CRCs) in cancer patients with central venous catheters (CVCs)", Journal of Clinical Oncology ,2002,21,    ,['citation-journal']," Reichardt P, Kretzschmar A, Biakhov M, Irwin D, Slabber C, Miller L, et al. A phase III randomized, double‐blind, placebo‐controlled study evaluating the efficacy and safety of daily low‐molecular‐weight heparin (dalteparin sodium, Fragmin) in preventing catheter‐related complications (CRCs) in cancer patients with central venous catheters (CVCs).  Journal of Clinical Oncology 2002;21:1474. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+phase+III+randomized,+double‐blind,+placebo‐controlled+study+evaluating+the+efficacy+and+safety+of+daily+low‐molecular‐weight+heparin+(dalteparin+sodium,+Fragmin)+in+preventing+catheter‐related+complications+(CRCs)+in+cancer+patients+with+central+venous+catheters+(CVCs)+&author=P+Reichardt&author=A+Kretzschmar&author=M+Biakhov&author=D+Irwin&author=C+Slabber&author=L+Miller&publication_year=2002&hl=en']",,, Karthaus 2006 {published data only}  ,included,CD006468-bbs2-0005,
CD006468-bib-0011,"Lavau‐Denes S, Lacroix P, Maubon A, Preux P, Genet D, Venat‐Bouvet L, et al. ","Prophylaxis of catheter‐related deep vein thrombosis in cancer patients with low‐dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study", Annals of Oncology ,2012,23,    ,['citation-journal']," Lavau‐Denes S, Lacroix P, Maubon A, Preux P, Genet D, Venat‐Bouvet L, et al. Prophylaxis of catheter‐related deep vein thrombosis in cancer patients with low‐dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.  Annals of Oncology 2012;23(1546O PR):ix29. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0923-7534(20)34352-0', 'https://scholar.google.com/scholar_lookup?title=Prophylaxis+of+catheter‐related+deep+vein+thrombosis+in+cancer+patients+with+low‐dose+warfarin,+low+molecular+weight+heparin,+or+control:+a+randomized,+controlled,+phase+III+study+&author=S+Lavau‐Denes&author=P+Lacroix&author=A+Maubon&author=P+Preux&author=D+Genet&author=L+Venat‐Bouvet&publication_year=2012&hl=en']",,https://doi.org/10.1016/S0923-7534(20)34352-0, Lavau‐Denes 2013 {published data only}  ,included,CD006468-bbs2-0006,
CD006468-bib-0012,"Lavau‐Denes S, Lacroix P, Maubon A, Preux PM, Genet D, Vénat‐Bouvet L, et al. ","Prophylaxis of catheter‐related deep vein thrombosis in cancer patients with low‐dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study", Cancer Chemotherapy Pharmacology ,2013,72,    ,['citation-journal']," Lavau‐Denes S, Lacroix P, Maubon A, Preux PM, Genet D, Vénat‐Bouvet L, et al. Prophylaxis of catheter‐related deep vein thrombosis in cancer patients with low‐dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.  Cancer Chemotherapy Pharmacology 2013;72:65‐73. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1007/s00280-013-2169-y', 'https://www.ncbi.nlm.nih.gov/pubmed/23636449', 'https://scholar.google.com/scholar_lookup?title=Prophylaxis+of+catheter‐related+deep+vein+thrombosis+in+cancer+patients+with+low‐dose+warfarin,+low+molecular+weight+heparin,+or+control:+a+randomized,+controlled,+phase+III+study+&author=S+Lavau‐Denes&author=P+Lacroix&author=A+Maubon&author=PM+Preux&author=D+Genet&author=L+Vénat‐Bouvet&publication_year=2013&hl=en']",23636449,https://doi.org/10.1007/s00280-013-2169-y, Lavau‐Denes 2013 {published data only}  ,included,CD006468-bbs2-0006,
CD006468-bib-0013,"Massicotte P, Julian JA, Gent M, Shields K, Marzinotto V, Szechtman B, et al. ",An open‐label randomized controlled trial of low molecular weight heparin for the prevention of central venous line‐related thrombotic complications in children: the PROTEKT trial, Thrombosis Research ,2003,109,    ,['citation-journal']," Massicotte P, Julian JA, Gent M, Shields K, Marzinotto V, Szechtman B, et al. An open‐label randomized controlled trial of low molecular weight heparin for the prevention of central venous line‐related thrombotic complications in children: the PROTEKT trial.  Thrombosis Research 2003;109(2‐3):101‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0049-3848(03)00099-9', 'https://www.ncbi.nlm.nih.gov/pubmed/12706638', 'https://scholar.google.com/scholar_lookup?title=An+open‐label+randomized+controlled+trial+of+low+molecular+weight+heparin+for+the+prevention+of+central+venous+line‐related+thrombotic+complications+in+children:+the+PROTEKT+trial+&author=P+Massicotte&author=JA+Julian&author=M+Gent&author=K+Shields&author=V+Marzinotto&author=B+Szechtman&publication_year=2003&hl=en']",12706638,https://doi.org/10.1016/S0049-3848(03)00099-9, Massicotte 2003 {published data only}  ,included,CD006468-bbs2-0007,
CD006468-bib-0014,"Mismetti P, Mille D, Laporte S, Charlet V, Buchmuller‐Cordier A, Jacquin JP, et al. ",Low‐molecular‐weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long‐term central venous catheters: a pilot randomized trial, Haematologica ,2003,88,    ,['citation-journal']," Mismetti P, Mille D, Laporte S, Charlet V, Buchmuller‐Cordier A, Jacquin JP, et al. Low‐molecular‐weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long‐term central venous catheters: a pilot randomized trial.  Haematologica 2003;88(1):67‐73. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/12551829', 'https://scholar.google.com/scholar_lookup?title=Low‐molecular‐weight+heparin+(nadroparin)+and+very+low+doses+of+warfarin+in+the+prevention+of+upper+extremity+thrombosis+in+cancer+patients+with+indwelling+long‐term+central+venous+catheters:+a+pilot+randomized+trial+&author=P+Mismetti&author=D+Mille&author=S+Laporte&author=V+Charlet&author=A+Buchmuller‐Cordier&author=JP+Jacquin&publication_year=2003&hl=en']",12551829,, Mismetti 2003 {published data only}  ,included,CD006468-bbs2-0008,
CD006468-bib-0015,"Monreal M, Alastrue A, Rull M, Mira X, Muxart J, Rosell R, et al. ",Upper extremity deep venous thrombosis in cancer patients with venous access devices ‐ prophylaxis with a low molecular weight heparin (Fragmin), Thrombosis & Haemostasis ,1996,75,    ,['citation-journal']," Monreal M, Alastrue A, Rull M, Mira X, Muxart J, Rosell R, et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices ‐ prophylaxis with a low molecular weight heparin (Fragmin).  Thrombosis & Haemostasis 1996;75(2):251‐3. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1055/s-0038-1650254', 'https://scholar.google.com/scholar_lookup?title=Upper+extremity+deep+venous+thrombosis+in+cancer+patients+with+venous+access+devices+‐+prophylaxis+with+a+low+molecular+weight+heparin+(Fragmin)+&author=M+Monreal&author=A+Alastrue&author=M+Rull&author=X+Mira&author=J+Muxart&author=R+Rosell&publication_year=1996&hl=en']",,https://doi.org/10.1055/s-0038-1650254, Monreal 1996 {published data only}  ,included,CD006468-bbs2-0009,
CD006468-bib-0016,"Niers TM, Di Nisio M, Klerk CP, Baarslag HJ, Buller HR, Biemond BJ. ","Prevention of catheter‐related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo‐controlled study", Journal of Thrombosis and Haemostasis ,2007,5,    ,['citation-journal']," Niers TM, Di Nisio M, Klerk CP, Baarslag HJ, Buller HR, Biemond BJ. Prevention of catheter‐related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo‐controlled study.  Journal of Thrombosis and Haemostasis 2007;5(9):1878‐82. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/j.1538-7836.2007.02660.x', 'https://www.ncbi.nlm.nih.gov/pubmed/17723127', 'https://scholar.google.com/scholar_lookup?title=Prevention+of+catheter‐related+venous+thrombosis+with+nadroparin+in+patients+receiving+chemotherapy+for+hematologic+malignancies:+a+randomized,+placebo‐controlled+study+&author=TM+Niers&author=M+Nisio&author=CP+Klerk&author=HJ+Baarslag&author=HR+Buller&author=BJ+Biemond&publication_year=2007&hl=en']",17723127,https://doi.org/10.1111/j.1538-7836.2007.02660.x, Niers 2007 {published data only}  ,included,CD006468-bbs2-0010,
CD006468-bib-0017,"Ruud E, Holmstrom H, Hopp E, Wesenberg F. ","Low dose warfarin for the prevention of central line‐associated thrombosis in children with malignancies ‐ a randomized, controlled study", Acta Paediatrica ,2006,95,    ,['citation-journal']," Ruud E, Holmstrom H, Hopp E, Wesenberg F. Low dose warfarin for the prevention of central line‐associated thrombosis in children with malignancies ‐ a randomized, controlled study.  Acta Paediatrica 2006;95(9):1053‐9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1080/08035250600729092', 'https://www.ncbi.nlm.nih.gov/pubmed/16938749', 'https://scholar.google.com/scholar_lookup?title=Low+dose+warfarin+for+the+prevention+of+central+line‐associated+thrombosis+in+children+with+malignancies+‐+a+randomized,+controlled+study+&author=E+Ruud&author=H+Holmstrom&author=E+Hopp&author=F+Wesenberg&publication_year=2006&hl=en']",16938749,https://doi.org/10.1080/08035250600729092, Ruud 2006 {published data only}  ,included,CD006468-bbs2-0011,
CD006468-bib-0018,"Agnelli G, Verso M, Bertoglio S, Ageno W, Bazzan M, Parise P, et al. ",A double‐blind placebo‐controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter,,2004,,    ,['citation-other']," Agnelli G, Verso M, Bertoglio S, Ageno W, Bazzan M, Parise P, et al. A double‐blind placebo‐controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter. Journal of Clinical Oncology. 2004; Vol. 22:734S. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+double‐blind+placebo‐controlled+randomized+study+on+the+efficacy+and+safety+of+enoxaparin+for+the+prevention+of+upper+limb+deep+vein+thrombosis+in+cancer+patients+with+central+vein+catheter+&author=G+Agnelli&author=M+Verso&author=S+Bertoglio&author=W+Ageno&author=M+Bazzan&author=P+Parise&publication_year=2004&hl=en']",,, Verso 2008 {published data only}  ,included,CD006468-bbs2-0012,
CD006468-bib-0019,"Verso M, Agnelli G, Bertoglio S, Di Somma C, Paoletti F, Ageno W, et al. ",A double‐blind placebo‐controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter, Journal of Thrombosis and Haemostasis : JTH ,2003,1,    ,['citation-journal']," Verso M, Agnelli G, Bertoglio S, Di Somma C, Paoletti F, Ageno W, et al. A double‐blind placebo‐controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter.  Journal of Thrombosis and Haemostasis : JTH 2003;1:P0825. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+double‐blind+placebo‐controlled+randomized+study+on+the+efficacy+and+safety+of+enoxaparin+for+the+prevention+of+upper+limb+deep+vein+thrombosis+in+cancer+patients+with+central+vein+catheter+&author=M+Verso&author=G+Agnelli&author=S+Bertoglio&author=C+Somma&author=F+Paoletti&author=W+Ageno&publication_year=2003&hl=en']",,, Verso 2008 {published data only}  ,included,CD006468-bbs2-0012,
CD006468-bib-0020,"Verso M, Agnelli G, Bertoglio S, Di Somma FC, Paoletti F, Ageno W, et al. ","Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double‐blind, placebo‐controlled, randomized study in cancer patients", Journal of Clinical Oncology ,2005,23,    ,['citation-journal']," Verso M, Agnelli G, Bertoglio S, Di Somma FC, Paoletti F, Ageno W, et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double‐blind, placebo‐controlled, randomized study in cancer patients.  Journal of Clinical Oncology 2005;23(18):4057‐62. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1200/JCO.2005.06.084', 'https://www.ncbi.nlm.nih.gov/pubmed/15767643', 'https://scholar.google.com/scholar_lookup?title=Enoxaparin+for+the+prevention+of+venous+thromboembolism+associated+with+central+vein+catheter:+a+double‐blind,+placebo‐controlled,+randomized+study+in+cancer+patients+&author=M+Verso&author=G+Agnelli&author=S+Bertoglio&author=FC+Somma&author=F+Paoletti&author=W+Ageno&publication_year=2005&hl=en']",15767643,https://doi.org/10.1200/JCO.2005.06.084, Verso 2008 {published data only}  ,included,CD006468-bbs2-0012,
CD006468-bib-0021,"Verso M, Agnelli G, Kamphuisen PW, Ageno W, Bazzan M, Lazzaro A, et al. ",Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients, Internal and Emergency Medicine ,2008,3,    ,['citation-journal']," Verso M, Agnelli G, Kamphuisen PW, Ageno W, Bazzan M, Lazzaro A, et al. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients.  Internal and Emergency Medicine 2008;3(2):117‐22. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1007/s11739-008-0125-3', 'https://www.ncbi.nlm.nih.gov/pubmed/18317868', 'https://scholar.google.com/scholar_lookup?title=Risk+factors+for+upper+limb+deep+vein+thrombosis+associated+with+the+use+of+central+vein+catheter+in+cancer+patients+&author=M+Verso&author=G+Agnelli&author=PW+Kamphuisen&author=W+Ageno&author=M+Bazzan&author=A+Lazzaro&publication_year=2008&hl=en']",18317868,https://doi.org/10.1007/s11739-008-0125-3, Verso 2008 {published data only}  ,included,CD006468-bbs2-0012,
CD006468-bib-0022,"Young AM, Begum G, Billingham LJ, Hughes AI, Kerr DJ, Rea D, et al. ",WARP ‐ a multicenter prospective randomised controlled trial (RCT) of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs), Journal of Clinical Oncology ,2005,23,    ,['citation-journal']," Young AM, Begum G, Billingham LJ, Hughes AI, Kerr DJ, Rea D, et al. WARP ‐ a multicenter prospective randomised controlled trial (RCT) of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs).  Journal of Clinical Oncology 2005;23(16S):8004. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=WARP+‐+a+multicenter+prospective+randomised+controlled+trial+(RCT)+of+thrombosis+prophylaxis+with+warfarin+in+cancer+patients+with+central+venous+catheters+(CVCs)+&author=AM+Young&author=G+Begum&author=LJ+Billingham&author=AI+Hughes&author=DJ+Kerr&author=D+Rea&publication_year=2005&hl=en']",,, Young 2009 {published data only}  ,included,CD006468-bbs2-0013,
CD006468-bib-0023,"Young AM, Billingham LJ, Begum G, Kerr DJ, Hughes AI, Rea DW, et al. ",Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open‐label randomised trial, Lancet ,2009,373,    ,['citation-journal']," Young AM, Billingham LJ, Begum G, Kerr DJ, Hughes AI, Rea DW, et al. Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open‐label randomised trial.  Lancet 2009;373(9663):567‐74. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0140-6736(09)60205-1', 'https://www.ncbi.nlm.nih.gov/pubmed/19217991', 'https://scholar.google.com/scholar_lookup?title=Warfarin+thromboprophylaxis+in+cancer+patients+with+central+venous+catheters+(WARP):+an+open‐label+randomised+trial+&author=AM+Young&author=LJ+Billingham&author=G+Begum&author=DJ+Kerr&author=AI+Hughes&author=DW+Rea&publication_year=2009&hl=en']",19217991,https://doi.org/10.1016/S0140-6736(09)60205-1, Young 2009 {published data only}  ,included,CD006468-bbs2-0013,
CD006468-bib-0024,"Abdelkefi A, Othman BT, Kammoun L, Chelli M, Romdhane BN, Kriaa A, et al. ","Prevention of central venous line‐related thrombosis by continuous infusion of low‐dose unfractionated heparin, in patients with haemato‐ontological disease ‐ a randomized controlled trial", Thrombosis and Haemostasis ,2004,92,    ,['citation-journal']," Abdelkefi A, Othman BT, Kammoun L, Chelli M, Romdhane BN, Kriaa A, et al. Prevention of central venous line‐related thrombosis by continuous infusion of low‐dose unfractionated heparin, in patients with haemato‐ontological disease ‐ a randomized controlled trial.  Thrombosis and Haemostasis 2004;92(3):654‐61. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/15351864', 'https://scholar.google.com/scholar_lookup?title=Prevention+of+central+venous+line‐related+thrombosis+by+continuous+infusion+of+low‐dose+unfractionated+heparin,+in+patients+with+haemato‐ontological+disease+‐+a+randomized+controlled+trial+&author=A+Abdelkefi&author=BT+Othman&author=L+Kammoun&author=M+Chelli&author=BN+Romdhane&author=A+Kriaa&publication_year=2004&hl=en']",15351864,, Abdelkefi 2004 {published data only}  ,excluded,CD006468-bbs2-0014," Concerns about the accuracy and validity of the data reported, and the practical aspects of the published protocol. When asked by the review authors, the authors were unable to provide evidence that the study had been conducted.  "
CD006468-bib-0025,"Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D'Angelo A, et al. ",Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery, New England Journal of Medicine ,1998,339,    ,['citation-journal']," Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D'Angelo A, et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.  New England Journal of Medicine 1998;339:80‐5. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1056/NEJM199807093390204', 'https://www.ncbi.nlm.nih.gov/pubmed/9654538', ""https://scholar.google.com/scholar_lookup?title=Enoxaparin+plus+compression+stockings+compared+with+compression+stockings+alone+in+the+prevention+of+venous+thromboembolism+after+elective+neurosurgery+&author=G+Agnelli&author=F+Piovella&author=P+Buoncristiani&author=P+Severi&author=M+Pini&author=A+D'Angelo&publication_year=1998&hl=en""]",9654538,https://doi.org/10.1056/NEJM199807093390204, Agnelli 1998 {published data only}  ,excluded,CD006468-bbs2-0015, Not the population of interest (participants without CVC) 
CD006468-bib-0026,"Agnelli G, Bergqvist D, Cohen AT, Gallus AS, Gent M. ",Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high‐risk abdominal surgery, British Journal of Surgery ,2005,92,    ,['citation-journal']," Agnelli G, Bergqvist D, Cohen AT, Gallus AS, Gent M. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high‐risk abdominal surgery.  British Journal of Surgery 2005;92(10):1212‐20. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1002/bjs.5154', 'https://www.ncbi.nlm.nih.gov/pubmed/16175516', 'https://scholar.google.com/scholar_lookup?title=Randomized+clinical+trial+of+postoperative+fondaparinux+versus+perioperative+dalteparin+for+prevention+of+venous+thromboembolism+in+high‐risk+abdominal+surgery+&author=G+Agnelli&author=D+Bergqvist&author=AT+Cohen&author=AS+Gallus&author=M+Gent&publication_year=2005&hl=en']",16175516,https://doi.org/10.1002/bjs.5154, Agnelli 2005b {published data only}  ,excluded,CD006468-bbs2-0016, Not the population of interest (participants without CVC) 
CD006468-bib-0027,"Agnelli G, Buller HR, Cohen A, Gallus AS, Lee TC, Pak R, et al. ",Apixaban for the treatment of venous thromboembolism in cancer patients: data from the amplify trial, Canadian Journal of Cardiology ,2014,30,    ,['citation-journal']," Agnelli G, Buller HR, Cohen A, Gallus AS, Lee TC, Pak R, et al. Apixaban for the treatment of venous thromboembolism in cancer patients: data from the amplify trial.  Canadian Journal of Cardiology 2014;30:S278. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.cjca.2014.07.493', 'https://scholar.google.com/scholar_lookup?title=Apixaban+for+the+treatment+of+venous+thromboembolism+in+cancer+patients:+data+from+the+amplify+trial+&author=G+Agnelli&author=HR+Buller&author=A+Cohen&author=AS+Gallus&author=TC+Lee&author=R+Pak&publication_year=2014&hl=en']",,https://doi.org/10.1016/j.cjca.2014.07.493, Agnelli 2015 (AMPLIFY) {published data only}  ,excluded,CD006468-bbs2-0017, Not the population of interest (participants with cancer with VTE); includes 2 reports 
CD006468-bib-0028,"Agnelli G, Buller HR, Cohen A, Gallus AS, Lee TC, Pak R, et al. ",Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial, Journal of Thrombosis and Haemostasis ,2015,13,    ,['citation-journal']," Agnelli G, Buller HR, Cohen A, Gallus AS, Lee TC, Pak R, et al. Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.  Journal of Thrombosis and Haemostasis 2015;13(12):2187‐91. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/jth.13153', 'https://www.ncbi.nlm.nih.gov/pubmed/26407753', 'https://scholar.google.com/scholar_lookup?title=Oral+apixaban+for+the+treatment+of+venous+thromboembolism+in+cancer+patients:+results+from+the+AMPLIFY+trial+&author=G+Agnelli&author=HR+Buller&author=A+Cohen&author=AS+Gallus&author=TC+Lee&author=R+Pak&publication_year=2015&hl=en']",26407753,https://doi.org/10.1111/jth.13153, Agnelli 2015 (AMPLIFY) {published data only}  ,excluded,CD006468-bbs2-0017, Not the population of interest (participants with cancer with VTE); includes 2 reports 
CD006468-bib-0029,"Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, et al. ",Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study, Blood Coagulation & Fibrinolysis ,2003,14,    ,['citation-journal']," Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, et al. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study.  Blood Coagulation & Fibrinolysis 2003;14(4):341‐6. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00001721-200306000-00004', 'https://scholar.google.com/scholar_lookup?title=Prevention+of+venous+thromboembolism+in+medical+patients+with+enoxaparin:+a+subgroup+analysis+of+the+MEDENOX+study+&author=R+Alikhan&author=AT+Cohen&author=S+Combe&author=MM+Samama&author=L+Desjardins&author=A+Eldor&publication_year=2003&hl=en']",,https://doi.org/10.1097/00001721-200306000-00004, Alikhan 2003 (MEDENOX) {published data only}  ,excluded,CD006468-bbs2-0018, Not the population of interest (participants without CVC); includes 2 reports 
CD006468-bib-0030,"Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, et al. ",A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients, New England Journal of Medicine ,1999,341,    ,['citation-journal']," Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients.  New England Journal of Medicine 1999;341(11):793‐800. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1056/NEJM199909093411103', 'https://www.ncbi.nlm.nih.gov/pubmed/10477777', 'https://scholar.google.com/scholar_lookup?title=A+comparison+of+enoxaparin+with+placebo+for+the+prevention+of+venous+thromboembolism+in+acutely+ill+medical+patients+&author=MM+Samama&author=AT+Cohen&author=JY+Darmon&author=L+Desjardins&author=A+Eldor&author=C+Janbon&publication_year=1999&hl=en']",10477777,https://doi.org/10.1056/NEJM199909093411103, Alikhan 2003 (MEDENOX) {published data only}  ,excluded,CD006468-bbs2-0018, Not the population of interest (participants without CVC); includes 2 reports 
CD006468-bib-0031,"Anderson AJ, Krasnow SH, Boyer MW, Raucheisen ML, Grant CE, Gasper OR, et al. ",Hickman catheter clots: a common occurrence despite daily heparin flushing, Cancer Treatment Reports ,1987,71,    ,['citation-journal']," Anderson AJ, Krasnow SH, Boyer MW, Raucheisen ML, Grant CE, Gasper OR, et al. Hickman catheter clots: a common occurrence despite daily heparin flushing.  Cancer Treatment Reports 1987;71(6):651‐3. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/3581105', 'https://scholar.google.com/scholar_lookup?title=Hickman+catheter+clots:+a+common+occurrence+despite+daily+heparin+flushing&author=AJ+Anderson&author=SH+Krasnow&author=MW+Boyer&author=ML+Raucheisen&author=CE+Grant&author=OR+Gasper&publication_year=1987&hl=en']",3581105,, Anderson 1987 {published data only}  ,excluded,CD006468-bbs2-0019, Not an RCT; no control group 
CD006468-bib-0032,"Anderson AJ, Krasnow SH, Boyer MW, Cutler DJ, Jones BD, Citron ML, et al. ",Thrombosis: the major Hickman catheter complication in patients with solid tumor, Chest ,1989,95,    ,['citation-journal']," Anderson AJ, Krasnow SH, Boyer MW, Cutler DJ, Jones BD, Citron ML, et al. Thrombosis: the major Hickman catheter complication in patients with solid tumor.  Chest 1989;95(1):71‐5. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1378/chest.95.1.71', 'https://www.ncbi.nlm.nih.gov/pubmed/2909358', 'https://scholar.google.com/scholar_lookup?title=Thrombosis:+the+major+Hickman+catheter+complication+in+patients+with+solid+tumor&author=AJ+Anderson&author=SH+Krasnow&author=MW+Boyer&author=DJ+Cutler&author=BD+Jones&author=ML+Citron&publication_year=1989&hl=en']",2909358,https://doi.org/10.1378/chest.95.1.71, Anderson 1989 {published data only}  ,excluded,CD006468-bbs2-0020, Not an RCT; observational study 
CD006468-bib-0033,"Attal M, Huguet F, Rubie H, Huynh A, Charlet JP, Payen JL, et al. ","Prevention of hepatic veno‐occlusive disease after bone marrow transplantation by continuous infusion of low‐dose heparin: a prospective, randomized trial", Blood ,1992,79,    ,['citation-journal']," Attal M, Huguet F, Rubie H, Huynh A, Charlet JP, Payen JL, et al. Prevention of hepatic veno‐occlusive disease after bone marrow transplantation by continuous infusion of low‐dose heparin: a prospective, randomized trial.  Blood 1992;79(11):2834‐40. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1182/blood.V79.11.2834.bloodjournal79112834', 'https://www.ncbi.nlm.nih.gov/pubmed/1586733', 'https://scholar.google.com/scholar_lookup?title=Prevention+of+hepatic+veno‐occlusive+disease+after+bone+marrow+transplantation+by+continuous+infusion+of+low‐dose+heparin:+a+prospective,+randomized+trial+&author=M+Attal&author=F+Huguet&author=H+Rubie&author=A+Huynh&author=JP+Charlet&author=JL+Payen&publication_year=1992&hl=en']",1586733,https://doi.org/10.1182/blood.V79.11.2834.bloodjournal79112834, Attal 1992 {published data only}  ,excluded,CD006468-bbs2-0021," Not population of interest (participants did not previously have CVC, it was rather inserted for intervention)  "
CD006468-bib-0034,"Auer R, Scheer A, Wells PS, Boushey R, Asmis T, Jonker D, et al. ",The use of extended perioperative low molecular weight heparin (tinzaparin) to improve disease‐free survival following surgical resection of colon cancer: a pilot randomized controlled trial, Blood Coagulation & Fibrinolysis ,2011,22,    ,['citation-journal']," Auer R, Scheer A, Wells PS, Boushey R, Asmis T, Jonker D, et al. The use of extended perioperative low molecular weight heparin (tinzaparin) to improve disease‐free survival following surgical resection of colon cancer: a pilot randomized controlled trial.  Blood Coagulation & Fibrinolysis 2011;22(8):760‐2. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/MBC.0b013e328349f1a8', 'https://scholar.google.com/scholar_lookup?title=The+use+of+extended+perioperative+low+molecular+weight+heparin+(tinzaparin)+to+improve+disease‐free+survival+following+surgical+resection+of+colon+cancer:+a+pilot+randomized+controlled+trial+&author=R+Auer&author=A+Scheer&author=PS+Wells&author=R+Boushey&author=T+Asmis&author=D+Jonker&publication_year=2011&hl=en']",,https://doi.org/10.1097/MBC.0b013e328349f1a8, Auer 2011 {published data only}  ,excluded,CD006468-bbs2-0022, Not the population of interest (participants without CVC) 
CD006468-bib-0035,"Barman B, Ghosh R, Mondal A, Saha K, Mukhopadhyay S, Mukhopadhyay A. ",Central venous catheters in bone marrow transplantation and leukemia patients,,2005,,    ,['citation-other']," Barman B, Ghosh R, Mondal A, Saha K, Mukhopadhyay S, Mukhopadhyay A. Central venous catheters in bone marrow transplantation and leukemia patients. Journal of Clinical Oncology2005:8269. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Central+venous+catheters+in+bone+marrow+transplantation+and+leukemia+patients&author=B+Barman&author=R+Ghosh&author=A+Mondal&author=K+Saha&author=S+Mukhopadhyay&author=A+Mukhopadhyay&publication_year=2005&hl=en']",,, Barman 2005 {published data only}  ,excluded,CD006468-bbs2-0023, Not an RCT; observational study 
CD006468-bib-0036,"Bigg SW, Catalona WJ. ",Prophylactic mini‐dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial, Urology ,1992,39,    ,['citation-journal']," Bigg SW, Catalona WJ. Prophylactic mini‐dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial.  Urology 1992;39(4):309‐13. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/0090-4295(92)90203-9', 'https://www.ncbi.nlm.nih.gov/pubmed/1557840', 'https://scholar.google.com/scholar_lookup?title=Prophylactic+mini‐dose+heparin+in+patients+undergoing+radical+retropubic+prostatectomy.+A+prospective+trial+&author=SW+Bigg&author=WJ+Catalona&publication_year=1992&hl=en']",1557840,https://doi.org/10.1016/0090-4295(92)90203-9, Bigg 1992 {published data only}  ,excluded,CD006468-bbs2-0024, Not the population of interest (participants without CVC) 
CD006468-bib-0037,"Boraks P, Seale J, Price J, Bass G, Ethell M, Keeling D, et al. ",Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies, British Journal of Haematology ,1998,101,    ,['citation-journal']," Boraks P, Seale J, Price J, Bass G, Ethell M, Keeling D, et al. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies.  British Journal of Haematology 1998;101(3):483‐6. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1046/j.1365-2141.1998.00732.x', 'https://www.ncbi.nlm.nih.gov/pubmed/9633891', 'https://scholar.google.com/scholar_lookup?title=Prevention+of+central+venous+catheter+associated+thrombosis+using+minidose+warfarin+in+patients+with+haematological+malignancies+&author=P+Boraks&author=J+Seale&author=J+Price&author=G+Bass&author=M+Ethell&author=D+Keeling&publication_year=1998&hl=en']",9633891,https://doi.org/10.1046/j.1365-2141.1998.00732.x, Boraks 1998 {published data only}  ,excluded,CD006468-bbs2-0025, Not an RCT; historic control 
CD006468-bib-0038,"Cahan MA, Hanna DJ, Wiley LA, Cox DK, Killewich LA. ",External pneumatic compression and fibrinolysis in abdominal surgery, Journal of Vascular Surgery ,2000,32,    ,['citation-journal']," Cahan MA, Hanna DJ, Wiley LA, Cox DK, Killewich LA. External pneumatic compression and fibrinolysis in abdominal surgery.  Journal of Vascular Surgery 2000;32(3):537‐43. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1067/mva.2000.107572', 'https://www.ncbi.nlm.nih.gov/pubmed/10957661', 'https://scholar.google.com/scholar_lookup?title=External+pneumatic+compression+and+fibrinolysis+in+abdominal+surgery&author=MA+Cahan&author=DJ+Hanna&author=LA+Wiley&author=DK+Cox&author=LA+Killewich&publication_year=2000&hl=en']",10957661,https://doi.org/10.1067/mva.2000.107572, Cahan 2000 {published data only}  ,excluded,CD006468-bbs2-0026, Not the population of interest (participants without CVC) 
CD006468-bib-0039,"Ciftci A, Altiay G. ",The effect of warfarin on survival in patients with lung cancer, Journal of Thoracic Oncology ,2012,7,    ,['citation-journal']," Ciftci A, Altiay G. The effect of warfarin on survival in patients with lung cancer.  Journal of Thoracic Oncology 2012;7(7):S122. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+effect+of+warfarin+on+survival+in+patients+with+lung+cancer&author=A+Ciftci&author=G+Altiay&publication_year=2012&hl=en']",,, Ciftci 2012 {published data only}  ,excluded,CD006468-bbs2-0027, Not the population of interest (participants without CVC) 
CD006468-bib-0040,"Clarke‐Pearson DL, Synan IS, Dodge R, Soper JT, Berchuck A, Coleman RE. ",A randomized trial of low‐dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery, American Journal of Obstetrics and Gynecology ,1993,168,    ,['citation-journal']," Clarke‐Pearson DL, Synan IS, Dodge R, Soper JT, Berchuck A, Coleman RE. A randomized trial of low‐dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery.  American Journal of Obstetrics and Gynecology 1993;168(4):1146‐54. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/0002-9378(93)90360-U', 'https://www.ncbi.nlm.nih.gov/pubmed/8475960', 'https://scholar.google.com/scholar_lookup?title=A+randomized+trial+of+low‐dose+heparin+and+intermittent+pneumatic+calf+compression+for+the+prevention+of+deep+venous+thrombosis+after+gynecologic+oncology+surgery+&author=DL+Clarke‐Pearson&author=IS+Synan&author=R+Dodge&author=JT+Soper&author=A+Berchuck&author=RE+Coleman&publication_year=1993&hl=en']",8475960,https://doi.org/10.1016/0002-9378(93)90360-U, Clarke‐Pearson 1993 {published data only}  ,excluded,CD006468-bbs2-0028, Not the population of interest (participants without CVC) 
CD006468-bib-0041,"Cohen AT, Wagner MB, Mohamed MS. ",Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis, American Journal of Surgery ,1997,174,    ,['citation-journal']," Cohen AT, Wagner MB, Mohamed MS. Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis.  American Journal of Surgery 1997;174(1):1‐5. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0002-9610(97)00050-0', 'https://www.ncbi.nlm.nih.gov/pubmed/9240942', 'https://scholar.google.com/scholar_lookup?title=Risk+factors+for+bleeding+in+major+abdominal+surgery+using+heparin+thromboprophylaxis&author=AT+Cohen&author=MB+Wagner&author=MS+Mohamed&publication_year=1997&hl=en']",9240942,https://doi.org/10.1016/S0002-9610(97)00050-0, Cohen 1997 {published data only}  ,excluded,CD006468-bbs2-0029, Not the population of interest (participants without CVC) 
CD006468-bib-0042,"Kakkar VV, Cohen AT, Edmonson RA, Phillips MJ, Das SK, Maher KT, et al. ",Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery, Lancet ,1993,341,    ,['citation-journal']," Kakkar VV, Cohen AT, Edmonson RA, Phillips MJ, Das SK, Maher KT, et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery.  Lancet 1993;341(8840):259‐65. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/0140-6736(93)92614-Y', 'https://www.ncbi.nlm.nih.gov/pubmed/8093915', 'https://scholar.google.com/scholar_lookup?title=Low+molecular+weight+versus+standard+heparin+for+prevention+of+venous+thromboembolism+after+major+abdominal+surgery+&author=VV+Kakkar&author=AT+Cohen&author=RA+Edmonson&author=MJ+Phillips&author=SK+Das&author=KT+Maher&publication_year=1993&hl=en']",8093915,https://doi.org/10.1016/0140-6736(93)92614-Y, Cohen 1997 {published data only}  ,excluded,CD006468-bbs2-0029, Not the population of interest (participants without CVC) 
CD006468-bib-0043,"Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W, et al. ",Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial, BMJ ,2006,332,    ,['citation-journal']," Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.  BMJ 2006;332(7537):325‐9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1136/bmj.38733.466748.7C', 'https://www.ncbi.nlm.nih.gov/pubmed/16439370', 'https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+of+fondaparinux+for+the+prevention+of+venous+thromboembolism+in+older+acute+medical+patients:+randomised+placebo+controlled+trial+&author=AT+Cohen&author=BL+Davidson&author=AS+Gallus&author=MR+Lassen&author=MH+Prins&author=W+Tomkowski&publication_year=2006&hl=en']",16439370,https://doi.org/10.1136/bmj.38733.466748.7C, Cohen 2006 {published data only}  ,excluded,CD006468-bbs2-0030, Not the population of interest (participants without CVC) 
CD006468-bib-0044,"Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W, et al. ",Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial, BMJ ,2006,332,    ,['citation-journal']," Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.  BMJ 2006;332(7537):325‐9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1136/bmj.38733.466748.7C', 'https://www.ncbi.nlm.nih.gov/pubmed/16439370', 'https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+of+fondaparinux+for+the+prevention+of+venous+thromboembolism+in+older+acute+medical+patients:+randomised+placebo+controlled+trial+&author=AT+Cohen&author=BL+Davidson&author=AS+Gallus&author=MR+Lassen&author=MH+Prins&author=W+Tomkowski&publication_year=2006&hl=en']",16439370,https://doi.org/10.1136/bmj.38733.466748.7C, Cohen 2007 (PREVENT) {published data only}  ,excluded,CD006468-bbs2-0031, Not the population of interest (participants without CVC); included 3 reports 
CD006468-bib-0045,"Cohen AT, Turpie AG, Leizorovicz A, Olsson CG, Vaitkus PT, Goldhaber SZ. ",Thromboprophylaxis with dalteparin in medical patients: which patients benefit?, Vascular Medicine ,2007,12,    ,['citation-journal']," Cohen AT, Turpie AG, Leizorovicz A, Olsson CG, Vaitkus PT, Goldhaber SZ. Thromboprophylaxis with dalteparin in medical patients: which patients benefit?.  Vascular Medicine 2007;12(2):123‐7. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1177/1358863X07079017', 'https://www.ncbi.nlm.nih.gov/pubmed/17615800', 'https://scholar.google.com/scholar_lookup?title=Thromboprophylaxis+with+dalteparin+in+medical+patients:+which+patients+benefit?&author=AT+Cohen&author=AG+Turpie&author=A+Leizorovicz&author=CG+Olsson&author=PT+Vaitkus&author=SZ+Goldhaber&publication_year=2007&hl=en']",17615800,https://doi.org/10.1177/1358863X07079017, Cohen 2007 (PREVENT) {published data only}  ,excluded,CD006468-bbs2-0031, Not the population of interest (participants without CVC); included 3 reports 
CD006468-bib-0046,"Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ, PREVENT Medical Thromboprophylaxis Study Group. ","Randomized, placebo‐controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients", Circulation ,2004,110,    ,['citation-journal']," Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ, PREVENT Medical Thromboprophylaxis Study Group. Randomized, placebo‐controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.  Circulation 2004;110(7):874‐9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/01.CIR.0000138928.83266.24', 'https://www.ncbi.nlm.nih.gov/pubmed/15289368', 'https://scholar.google.com/scholar_lookup?title=Randomized,+placebo‐controlled+trial+of+dalteparin+for+the+prevention+of+venous+thromboembolism+in+acutely+ill+medical+patients+&author=A+Leizorovicz&author=AT+Cohen&author=AG+Turpie&author=CG+Olsson&author=PT+Vaitkus&author=SZ+Goldhaber&publication_year=2004&hl=en']",15289368,https://doi.org/10.1161/01.CIR.0000138928.83266.24, Cohen 2007 (PREVENT) {published data only}  ,excluded,CD006468-bbs2-0031, Not the population of interest (participants without CVC); included 3 reports 
CD006468-bib-0047,"Conte GF, Aravena PC, Fardella PD, Araos DM, Alfaro JI, Flores CA, et al. ",Prophylaxis of venous thrombosis (VT) associated with central venous catheter (CVC) with low molecular weight heparin (LMWH) in hematologic malignancies, Blood ,2003,102,    ,['citation-journal']," Conte GF, Aravena PC, Fardella PD, Araos DM, Alfaro JI, Flores CA, et al. Prophylaxis of venous thrombosis (VT) associated with central venous catheter (CVC) with low molecular weight heparin (LMWH) in hematologic malignancies.  Blood 2003;102(11):4195. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Prophylaxis+of+venous+thrombosis+(VT)+associated+with+central+venous+catheter+(CVC)+with+low+molecular+weight+heparin+(LMWH)+in+hematologic+malignancies+&author=GF+Conte&author=PC+Aravena&author=PD+Fardella&author=DM+Araos&author=JI+Alfaro&author=CA+Flores&publication_year=2003&hl=en']",,, Conte 2003 {published data only}  ,excluded,CD006468-bbs2-0032, No obtainable needed data from study authors 
CD006468-bib-0048,"Curigliano G, Mandalà M, Bucciarelli P, Peruzzotti G, Colleoni M, Biffi R, et al. ",Factor V Leiden mutation in patients with breast cancer and a central venous catheter: relationship with deep vein thrombosis, Journal of Clinical Oncology ,2004,22,    ,['citation-journal']," Curigliano G, Mandalà M, Bucciarelli P, Peruzzotti G, Colleoni M, Biffi R, et al. Factor V Leiden mutation in patients with breast cancer and a central venous catheter: relationship with deep vein thrombosis.  Journal of Clinical Oncology 2004;22:8020. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1200/jco.2004.22.90140.8020', 'https://scholar.google.com/scholar_lookup?title=Factor+V+Leiden+mutation+in+patients+with+breast+cancer+and+a+central+venous+catheter:+relationship+with+deep+vein+thrombosis+&author=G+Curigliano&author=+Mandalà\xa0M&author=P+Bucciarelli&author=G+Peruzzotti&author=M+Colleoni&author=R+Biffi&publication_year=2004&hl=en']",,https://doi.org/10.1200/jco.2004.22.90140.8020, Curigliano 2004 {published data only}  ,excluded,CD006468-bbs2-0033, Not an RCT; retrospective study 
CD006468-bib-0049,"Dickinson LD, Miller LD, Patel CP, Gupta SK. ",Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors, Neurosurgery ,1998,43,    ,['citation-journal']," Dickinson LD, Miller LD, Patel CP, Gupta SK. Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors.  Neurosurgery 1998;43(5):1074‐81. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/00006123-199811000-00039', 'https://www.ncbi.nlm.nih.gov/pubmed/9802851', 'https://scholar.google.com/scholar_lookup?title=Enoxaparin+increases+the+incidence+of+postoperative+intracranial+hemorrhage+when+initiated+preoperatively+for+deep+venous+thrombosis+prophylaxis+in+patients+with+brain+tumors+&author=LD+Dickinson&author=LD+Miller&author=CP+Patel&author=SK+Gupta&publication_year=1998&hl=en']",9802851,https://doi.org/10.1097/00006123-199811000-00039, Dickinson 1998 {published data only}  ,excluded,CD006468-bbs2-0034, Not the population of interest (participants without CVC) 
CD006468-bib-0050,"Dillon PW, Jones GR, Bagnall‐Reeb HA, Buckley JD, Wiener ES, Haase GM. ",Prophylactic urokinase in the management of long‐term venous access devices in children: a Children's Oncology Group study, Journal of Clinical Oncology ,2004,22,    ,['citation-journal']," Dillon PW, Jones GR, Bagnall‐Reeb HA, Buckley JD, Wiener ES, Haase GM. Prophylactic urokinase in the management of long‐term venous access devices in children: a Children's Oncology Group study.  Journal of Clinical Oncology 2004;22(13):2718‐23. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1200/JCO.2004.07.019', 'https://www.ncbi.nlm.nih.gov/pubmed/15226339', ""https://scholar.google.com/scholar_lookup?title=Prophylactic+urokinase+in+the+management+of+long‐term+venous+access+devices+in+children:+a+Children's+Oncology+Group+study+&author=PW+Dillon&author=GR+Jones&author=HA+Bagnall‐Reeb&author=JD+Buckley&author=ES+Wiener&author=GM+Haase&publication_year=2004&hl=en""]",15226339,https://doi.org/10.1200/JCO.2004.07.019, Dillon 2004 {published data only}  ,excluded,CD006468-bbs2-0035, Inadequate control groups; intervention compared with urokinase 
CD006468-bib-0051,Freytes C. ,Thromboembolic complications related to indwelling central venous catheters in children, Current Opinion in Oncology ,2003,15,    ,['citation-journal'], Freytes C. Thromboembolic complications related to indwelling central venous catheters in children.  Current Opinion in Oncology 2003;15(4):289‐92. CENTRAL    Link to article     PubMed     Google Scholar     ,"['', 'https://doi.org/10.1097/00001622-200307000-00002', 'https://www.ncbi.nlm.nih.gov/pubmed/12874506', 'https://scholar.google.com/scholar_lookup?title=Thromboembolic+complications+related+to+indwelling+central+venous+catheters+in+children&author=C+Freytes&publication_year=2003&hl=en']",12874506,https://doi.org/10.1097/00001622-200307000-00002, Freytes 2003 {published data only}  ,excluded,CD006468-bbs2-0036, Review 
CD006468-bib-0052,"Goldhaber SZ, Dunn K, Gerhard‐Herman M, Park JK, Black PM. ",Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis, Chest ,2002,122,    ,['citation-journal']," Goldhaber SZ, Dunn K, Gerhard‐Herman M, Park JK, Black PM. Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis.  Chest 2002;122(6):1933‐7. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1378/chest.122.6.1933', 'https://www.ncbi.nlm.nih.gov/pubmed/12475829', 'https://scholar.google.com/scholar_lookup?title=Low+rate+of+venous+thromboembolism+after+craniotomy+for+brain+tumor+using+multimodality+prophylaxis+&author=SZ+Goldhaber&author=K+Dunn&author=M+Gerhard‐Herman&author=JK+Park&author=PM+Black&publication_year=2002&hl=en']",12475829,https://doi.org/10.1378/chest.122.6.1933, Goldhaber 2002 {published data only}  ,excluded,CD006468-bbs2-0037, Not the population of interest (participants without CVC) 
CD006468-bib-0053,"Gould JR, Riggs B. ",Warfarin (WP) dose and incidence of port‐related thrombotic complications (CMPs) in cancer patients (pts), Journal of Clinical Oncology ,1996,15,    ,['citation-journal']," Gould JR, Riggs B. Warfarin (WP) dose and incidence of port‐related thrombotic complications (CMPs) in cancer patients (pts).  Journal of Clinical Oncology 1996;15:15. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Warfarin+(WP)+dose+and+incidence+of+port‐related+thrombotic+complications+(CMPs)+in+cancer+patients+(pts)+&author=JR+Gould&author=B+Riggs&publication_year=1996&hl=en']",,, Gould 1996 {published data only}  ,excluded,CD006468-bbs2-0038, No obtainable needed data from study authors 
CD006468-bib-0054,"Bauersachs R, Schellong SM, Haas S, Tebbe U, Gerlach HE, Abletshauser C, et al. ",CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency, Thrombosis and Haemostasis ,2011,105,    ,['citation-journal']," Bauersachs R, Schellong SM, Haas S, Tebbe U, Gerlach HE, Abletshauser C, et al. CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency.  Thrombosis and Haemostasis 2011;105(6):981‐8. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/21505722', 'https://scholar.google.com/scholar_lookup?title=CERTIFY:+prophylaxis+of+venous+thromboembolism+in+patients+with+severe+renal+insufficiency&author=R+Bauersachs&author=SM+Schellong&author=S+Haas&author=U+Tebbe&author=HE+Gerlach&author=C+Abletshauser&publication_year=2011&hl=en']",21505722,, Haas 2011 {published data only}  ,excluded,CD006468-bbs2-0039, Not the population of interest (participants without CVC); included 3 reports 
CD006468-bib-0055,"Haas S, Schellong SM, Tebbe U, Gerlach HE, Bauersachs R, Abletshauser C, et al. ",CERTIFY: certoparin versus UFH to prevent venous thromboembolic events in the patients with cancer, Hämostaseologie ,2011,31,    ,['citation-journal']," Haas S, Schellong SM, Tebbe U, Gerlach HE, Bauersachs R, Abletshauser C, et al. CERTIFY: certoparin versus UFH to prevent venous thromboembolic events in the patients with cancer.  Hämostaseologie 2011;31(1):A10. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=CERTIFY:+certoparin+versus+UFH+to+prevent+venous+thromboembolic+events+in+the+patients+with+cancer+&author=S+Haas&author=SM+Schellong&author=U+Tebbe&author=HE+Gerlach&author=R+Bauersachs&author=C+Abletshauser&publication_year=2011&hl=en']",,, Haas 2011 {published data only}  ,excluded,CD006468-bbs2-0039, Not the population of interest (participants without CVC); included 3 reports 
CD006468-bib-0056,"Haas S, Schellong SM, Tebbe U, Gerlach HE, Bauersachs R, Melzer N, et al. ",Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer ‐ a subgroup analysis of CERTIFY, BMC Cancer ,2011,11,    ,['citation-journal']," Haas S, Schellong SM, Tebbe U, Gerlach HE, Bauersachs R, Melzer N, et al. Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer ‐ a subgroup analysis of CERTIFY.  BMC Cancer 2011;11:1. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1186/1471-2407-11-316', 'https://www.ncbi.nlm.nih.gov/pubmed/21194487', 'https://scholar.google.com/scholar_lookup?title=Heparin+based+prophylaxis+to+prevent+venous+thromboembolic+events+and+death+in+patients+with+cancer+‐+a+subgroup+analysis+of+CERTIFY+&author=S+Haas&author=SM+Schellong&author=U+Tebbe&author=HE+Gerlach&author=R+Bauersachs&author=N+Melzer&publication_year=2011&hl=en']",21194487,https://doi.org/10.1186/1471-2407-11-316, Haas 2011 {published data only}  ,excluded,CD006468-bbs2-0039, Not the population of interest (participants without CVC); included 3 reports 
CD006468-bib-0057,"Handrup MM, Fuursted K, Funch P, Møller JK, Schrøder H. ",Biofilm formation in long‐term central venous catheters in children with cancer: a randomized controlled open‐labelled trial of taurolidine versus heparin," APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica ",2012,120,    ,['citation-journal']," Handrup MM, Fuursted K, Funch P, Møller JK, Schrøder H. Biofilm formation in long‐term central venous catheters in children with cancer: a randomized controlled open‐labelled trial of taurolidine versus heparin.  APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica 2012;120(10):794‐801. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/j.1600-0463.2012.02910.x', 'https://www.ncbi.nlm.nih.gov/pubmed/22958287', 'https://scholar.google.com/scholar_lookup?title=Biofilm+formation+in+long‐term+central+venous+catheters+in+children+with+cancer:+a+randomized+controlled+open‐labelled+trial+of+taurolidine+versus+heparin+&author=MM+Handrup&author=K+Fuursted&author=P+Funch&author=JK+Møller&author=H+Schrøder&publication_year=2012&hl=en']",22958287,https://doi.org/10.1111/j.1600-0463.2012.02910.x, Handrup 2012 {published data only}  ,excluded,CD006468-bbs2-0040, Not intervention of interest (locking solution) 
CD006468-bib-0058,"Harenberg J, Roebruck P, Heene DL. ",Subcutaneous low‐molecular‐weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients, Pathophysiology of Haemostasis and Thrombosis ,1996,26,    ,['citation-journal']," Harenberg J, Roebruck P, Heene DL. Subcutaneous low‐molecular‐weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients.  Pathophysiology of Haemostasis and Thrombosis 1996;26(3):127‐39. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1159/000217198', 'https://scholar.google.com/scholar_lookup?title=Subcutaneous+low‐molecular‐weight+heparin+versus+standard+heparin+and+the+prevention+of+thromboembolism+in+medical+inpatients+&author=J+Harenberg&author=P+Roebruck&author=DL+Heene&publication_year=1996&hl=en']",,https://doi.org/10.1159/000217198, Harenberg 1996 {published data only}  ,excluded,CD006468-bbs2-0041, Not the population of interest (participants without CVC); included 2 reports 
CD006468-bib-0059,"Harenberg J, Roebruck P, Stehle G, Habscheid W, Biegholdt M, Heene DL. ",Heparin Study in Internal Medicine (HESIM): design and preliminary results, Thrombosis Research ,1992,68,    ,['citation-journal']," Harenberg J, Roebruck P, Stehle G, Habscheid W, Biegholdt M, Heene DL. Heparin Study in Internal Medicine (HESIM): design and preliminary results.  Thrombosis Research 1992;68(1):33‐43. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/0049-3848(92)90125-T', 'https://www.ncbi.nlm.nih.gov/pubmed/1333105', 'https://scholar.google.com/scholar_lookup?title=Heparin+Study+in+Internal+Medicine+(HESIM):+design+and+preliminary+results&author=J+Harenberg&author=P+Roebruck&author=G+Stehle&author=W+Habscheid&author=M+Biegholdt&author=DL+Heene&publication_year=1992&hl=en']",1333105,https://doi.org/10.1016/0049-3848(92)90125-T, Harenberg 1996 {published data only}  ,excluded,CD006468-bbs2-0041, Not the population of interest (participants without CVC); included 2 reports 
CD006468-bib-0060,"Hata K, Kimura T, Tsuzuki S, Ishii G, Kido M, Yamamoto T, et al. ",Safety of fondaparinux for prevention of postoperative venous thromboembolism in urological malignancy: a prospective randomized clinical trial, International Journal of Urology ,2016,23,    ,['citation-journal']," Hata K, Kimura T, Tsuzuki S, Ishii G, Kido M, Yamamoto T, et al. Safety of fondaparinux for prevention of postoperative venous thromboembolism in urological malignancy: a prospective randomized clinical trial.  International Journal of Urology 2016;23(11):923‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/iju.13189', 'https://www.ncbi.nlm.nih.gov/pubmed/27545448', 'https://scholar.google.com/scholar_lookup?title=Safety+of+fondaparinux+for+prevention+of+postoperative+venous+thromboembolism+in+urological+malignancy:+a+prospective+randomized+clinical+trial+&author=K+Hata&author=T+Kimura&author=S+Tsuzuki&author=G+Ishii&author=M+Kido&author=T+Yamamoto&publication_year=2016&hl=en']",27545448,https://doi.org/10.1111/iju.13189, Hata 2016 {published data only}  ,excluded,CD006468-bbs2-0042, Not the population of interest (participants without CVC) 
CD006468-bib-0061,"Henrickson KJ, Axtell RA, Hoover SM, Kuhn SM, Pritchett J, Kehl SC, et al. ","Prevention of central venous catheter‐related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double‐blind trial", Journal of Clinical Oncology ,2000,18,    ,['citation-journal']," Henrickson KJ, Axtell RA, Hoover SM, Kuhn SM, Pritchett J, Kehl SC, et al. Prevention of central venous catheter‐related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double‐blind trial.  Journal of Clinical Oncology 2000;18(6):1269‐78. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1200/JCO.2000.18.6.1269', 'https://www.ncbi.nlm.nih.gov/pubmed/10715297', 'https://scholar.google.com/scholar_lookup?title=Prevention+of+central+venous+catheter‐related+infections+and+thrombotic+events+in+immunocompromised+children+by+the+use+of+vancomycin/ciprofloxacin/heparin+flush+solution:+a+randomized,+multicenter,+double‐blind+trial+&author=KJ+Henrickson&author=RA+Axtell&author=SM+Hoover&author=SM+Kuhn&author=J+Pritchett&author=SC+Kehl&publication_year=2000&hl=en']",10715297,https://doi.org/10.1200/JCO.2000.18.6.1269, Henrickson 2000 {published data only}  ,excluded,CD006468-bbs2-0043, Different drug/agent studied 
CD006468-bib-0062,Hoffman KR. ,Subcutaneous ports used for vascular access need only be flushed every eight weeks to maintain patency, Journal of Clinical Oncology ,2001,20,    ,['citation-journal'], Hoffman KR. Subcutaneous ports used for vascular access need only be flushed every eight weeks to maintain patency.  Journal of Clinical Oncology 2001;20:1634. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Subcutaneous+ports+used+for+vascular+access+need+only+be+flushed+every+eight+weeks+to+maintain+patency+&author=KR+Hoffman&publication_year=2001&hl=en']",,, Hoffman 2001 {published data only}  ,excluded,CD006468-bbs2-0044, Different drug/agent studied 
CD006468-bib-0063,"Horne MK, McCloskey DJ, Calis K, Wesley R, Childs R, Kasten‐Sportes C. ",Use of heparin versus lepirudin flushes to prevent withdrawal occlusion of central venous access devices, Pharmacotherapy ,2006,26,    ,['citation-journal']," Horne MK, McCloskey DJ, Calis K, Wesley R, Childs R, Kasten‐Sportes C. Use of heparin versus lepirudin flushes to prevent withdrawal occlusion of central venous access devices.  Pharmacotherapy 2006;26(9):1262‐7. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1592/phco.26.9.1262', 'https://www.ncbi.nlm.nih.gov/pubmed/16945048', 'https://scholar.google.com/scholar_lookup?title=Use+of+heparin+versus+lepirudin+flushes+to+prevent+withdrawal+occlusion+of+central+venous+access+devices+&author=MK+Horne&author=DJ+McCloskey&author=K+Calis&author=R+Wesley&author=R+Childs&author=C+Kasten‐Sportes&publication_year=2006&hl=en']",16945048,https://doi.org/10.1592/phco.26.9.1262, Horne 2006 {published data only}  ,excluded,CD006468-bbs2-0045, Not intervention of interest (flushing solution) 
CD006468-bib-0064,Huisman MV. ,Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Yes for special patient groups, Journal of Thrombosis and Haemostasis ,2006,4,    ,['citation-journal'], Huisman MV. Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Yes for special patient groups.  Journal of Thrombosis and Haemostasis 2006;4(1):10‐3. CENTRAL    Link to article     PubMed     Google Scholar     ,"['', 'https://doi.org/10.1111/j.1538-7836.2005.01735.x', 'https://www.ncbi.nlm.nih.gov/pubmed/16409442', 'https://scholar.google.com/scholar_lookup?title=Is+antithrombotic+prophylaxis+required+in+cancer+patients+with+central+venous+catheters?+Yes+for+special+patient+groups+&author=MV+Huisman&publication_year=2006&hl=en']",16409442,https://doi.org/10.1111/j.1538-7836.2005.01735.x, Huisman 2006 {published data only}  ,excluded,CD006468-bbs2-0046, Review 
CD006468-bib-0065,"Iniesta P, Garcia T, Ayala F, Macias J, Flores B, Cava C, et al. ",Dalteparin is effective as prophylaxis of central venous catheter related thrombosis in cancer patients, Journal of Clinical Oncology ,2003,22,    ,['citation-journal']," Iniesta P, Garcia T, Ayala F, Macias J, Flores B, Cava C, et al. Dalteparin is effective as prophylaxis of central venous catheter related thrombosis in cancer patients.  Journal of Clinical Oncology 2003;22:3151. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Dalteparin+is+effective+as+prophylaxis+of+central+venous+catheter+related+thrombosis+in+cancer+patients+&author=P+Iniesta&author=T+Garcia&author=F+Ayala&author=J+Macias&author=B+Flores&author=C+Cava&publication_year=2003&hl=en']",,, Iniesta 2003 {published data only}  ,excluded,CD006468-bbs2-0047, Not an RCT; observational study 
CD006468-bib-0066,Jansson JH. ,Central venous catheter and malignant disease. The value of thrombosis prophylaxis is questioned now, Lakartidningen ,2005,102,    ,['citation-journal'], Jansson JH. Central venous catheter and malignant disease. The value of thrombosis prophylaxis is questioned now.  Lakartidningen 2005;102(26‐27):1984‐5. CENTRAL    PubMed     Google Scholar     ,"['', 'https://www.ncbi.nlm.nih.gov/pubmed/16044753', 'https://scholar.google.com/scholar_lookup?title=Central+venous+catheter+and+malignant+disease.+The+value+of+thrombosis+prophylaxis+is+questioned+now+&author=JH+Jansson&publication_year=2005&hl=en']",16044753,, Jansson 2005 {published data only}  ,excluded,CD006468-bbs2-0048, Review 
CD006468-bib-0067,"Kakkar VV, Balibrea J, Martinez‐Gonzalez J, Prandoni P. ",Late breaking clinical trial: a randomised double blind trial to evaluate the efficacy and safety of prolonging the thromboprophylaxis with bemiparin in patients undergoing cancer abdominal or pelvic surgery (the CANBESURE study), International Society on Thrombosis and Haemostasis ,2009,7,    ,['citation-journal']," Kakkar VV, Balibrea J, Martinez‐Gonzalez J, Prandoni P. Late breaking clinical trial: a randomised double blind trial to evaluate the efficacy and safety of prolonging the thromboprophylaxis with bemiparin in patients undergoing cancer abdominal or pelvic surgery (the CANBESURE study).  International Society on Thrombosis and Haemostasis 2009;7(Suppl 2):1202, LB‐MO‐002. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Late+breaking+clinical+trial:+a+randomised+double+blind+trial+to+evaluate+the+efficacy+and+safety+of+prolonging+the+thromboprophylaxis+with+bemiparin+in+patients+undergoing+cancer+abdominal+or+pelvic+surgery+(the+CANBESURE+study)+&author=VV+Kakkar&author=J+Balibrea&author=J+Martinez‐Gonzalez&author=P+Prandoni&publication_year=2009&hl=en']",,, Kakkar 2010 (CANBESURE) {published data only}  ,excluded,CD006468-bbs2-0049, Not the population of interest (participants without CVC); included 2 reports 
CD006468-bib-0068,"Kakkar VV, Balibrea JL, Martinez‐Gonzalez J, Prandoni P. ",Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study, Journal of Thrombosis and Haemostasis ,2010,8,    ,['citation-journal']," Kakkar VV, Balibrea JL, Martinez‐Gonzalez J, Prandoni P. Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study.  Journal of Thrombosis and Haemostasis 2010;8(6):1223‐9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/j.1538-7836.2010.03892.x', 'https://www.ncbi.nlm.nih.gov/pubmed/20456751', 'https://scholar.google.com/scholar_lookup?title=Extended+prophylaxis+with+bemiparin+for+the+prevention+of+venous+thromboembolism+after+abdominal+or+pelvic+surgery+for+cancer:+the+CANBESURE+randomized+study+&author=VV+Kakkar&author=JL+Balibrea&author=J+Martinez‐Gonzalez&author=P+Prandoni&publication_year=2010&hl=en']",20456751,https://doi.org/10.1111/j.1538-7836.2010.03892.x, Kakkar 2010 (CANBESURE) {published data only}  ,excluded,CD006468-bbs2-0049, Not the population of interest (participants without CVC); included 2 reports 
CD006468-bib-0069,"Kakkar AK, Agnelli G, Fisher W, George D, Lassen MR, Mismetti P, et al. SAVE‐ABDO Investigators. ",Preoperative enoxaparin versus postoperative semuloparin thromboprophylaxis in major abdominal surgery: a randomized controlled trial, Annals of Surgery ,2014,259,    ,['citation-journal']," Kakkar AK, Agnelli G, Fisher W, George D, Lassen MR, Mismetti P, et al. SAVE‐ABDO Investigators. Preoperative enoxaparin versus postoperative semuloparin thromboprophylaxis in major abdominal surgery: a randomized controlled trial.  Annals of Surgery 2014;259(6):1073‐9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/SLA.0000000000000430', 'https://www.ncbi.nlm.nih.gov/pubmed/24374549', 'https://scholar.google.com/scholar_lookup?title=Preoperative+enoxaparin+versus+postoperative+semuloparin+thromboprophylaxis+in+major+abdominal+surgery:+a+randomized+controlled+trial+&author=AK+Kakkar&author=G+Agnelli&author=W+Fisher&author=D+George&author=MR+Lassen&author=P+Mismetti&publication_year=2014&hl=en']",24374549,https://doi.org/10.1097/SLA.0000000000000430, Kakkar 2014 (SAVE‐ABDO) {published data only}  ,excluded,CD006468-bbs2-0050, Not the population of interest (participants without CVC); included 2 reports 
CD006468-bib-0070,"Kakkar AK, Agnelli G, Fisher WD, George D, Mouret P, Lassen MR, et al. ",The ultra‐low‐molecular‐weight heparin semuloparin for prevention of venous thromboembolism in patients undergoing major abdominal surgery, Blood ,2010,116,    ,['citation-journal']," Kakkar AK, Agnelli G, Fisher WD, George D, Mouret P, Lassen MR, et al. The ultra‐low‐molecular‐weight heparin semuloparin for prevention of venous thromboembolism in patients undergoing major abdominal surgery.  Blood 2010;116(21):188. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1182/blood.V116.21.188.188', 'https://scholar.google.com/scholar_lookup?title=The+ultra‐low‐molecular‐weight+heparin+semuloparin+for+prevention+of+venous+thromboembolism+in+patients+undergoing+major+abdominal+surgery+&author=AK+Kakkar&author=G+Agnelli&author=WD+Fisher&author=D+George&author=P+Mouret&author=MR+Lassen&publication_year=2010&hl=en']",,https://doi.org/10.1182/blood.V116.21.188.188, Kakkar 2014 (SAVE‐ABDO) {published data only}  ,excluded,CD006468-bbs2-0050, Not the population of interest (participants without CVC); included 2 reports 
CD006468-bib-0071,"Khorana AA, Francis CW, Kuderer N, Carrier M, Ortel TL, Wun T, et al. ",Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: a randomized trial, Blood ,2015,126,    ,['citation-journal']," Khorana AA, Francis CW, Kuderer N, Carrier M, Ortel TL, Wun T, et al. Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: a randomized trial.  Blood 2015;126(23):427. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1182/blood.V126.23.427.427', 'https://www.ncbi.nlm.nih.gov/pubmed/26065658', 'https://scholar.google.com/scholar_lookup?title=Dalteparin+thromboprophylaxis+in+cancer+patients+at+high+risk+for+venous+thromboembolism:+a+randomized+trial+&author=AA+Khorana&author=CW+Francis&author=N+Kuderer&author=M+Carrier&author=TL+Ortel&author=T+Wun&publication_year=2015&hl=en']",26065658,https://doi.org/10.1182/blood.V126.23.427.427, Khorana 2017 (PHACS) {published data only}  ,excluded,CD006468-bbs2-0051, Not the population of interest (participants without CVC); included 2 reports 
CD006468-bib-0072,"Khorana AA, Francis CW, Kuderer N, Carrier M, Ortel TL, Wun T, et al. ",Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: a randomized trial,,2017,,    ,['citation-other']," Khorana AA, Francis CW, Kuderer N, Carrier M, Ortel TL, Wun T, et al. Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: a randomized trial. Thrombosis Research2017. [DOI: dx.doi.org/10.1016/j.thromres.2017.01.009]CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Dalteparin+thromboprophylaxis+in+cancer+patients+at+high+risk+for+venous+thromboembolism:+a+randomized+trial+&author=AA+Khorana&author=CW+Francis&author=N+Kuderer&author=M+Carrier&author=TL+Ortel&author=T+Wun&publication_year=2017&hl=en']",,, Khorana 2017 (PHACS) {published data only}  ,excluded,CD006468-bbs2-0051, Not the population of interest (participants without CVC); included 2 reports 
CD006468-bib-0073,"Klerk CP, Smorenburg SM, Buller HR. ",Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review, Archives of Internal Medicine ,2003,163,    ,['citation-journal']," Klerk CP, Smorenburg SM, Buller HR. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review.  Archives of Internal Medicine 2003;163(16):1913‐21. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1001/archinte.163.16.1913', 'https://www.ncbi.nlm.nih.gov/pubmed/12963564', 'https://scholar.google.com/scholar_lookup?title=Thrombosis+prophylaxis+in+patient+populations+with+a+central+venous+catheter:+a+systematic+review+&author=CP+Klerk&author=SM+Smorenburg&author=HR+Buller&publication_year=2003&hl=en']",12963564,https://doi.org/10.1001/archinte.163.16.1913, Klerk 2003 {published data only}  ,excluded,CD006468-bbs2-0052, Review 
CD006468-bib-0074,"Klerk CP, Buller HR. ",Thrombosis prophylaxis in cancer patients with a central venous catheter ‐ in reply, Archives of Internal Medicine ,2004,164,    ,['citation-journal']," Klerk CP, Buller HR. Thrombosis prophylaxis in cancer patients with a central venous catheter ‐ in reply.  Archives of Internal Medicine 2004;164(4):459‐60. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1001/archinte.164.4.459-b', 'https://www.ncbi.nlm.nih.gov/pubmed/14980999', 'https://scholar.google.com/scholar_lookup?title=Thrombosis+prophylaxis+in+cancer+patients+with+a+central+venous+catheter+‐+in+reply&author=CP+Klerk&author=HR+Buller&publication_year=2004&hl=en']",14980999,https://doi.org/10.1001/archinte.164.4.459-b, Klerk 2004 {published data only}  ,excluded,CD006468-bbs2-0053, Letter to the editor 
CD006468-bib-0075,"Koppenhagen K, Adolf J, Matthes M, Tröster E, Roder JD, Hass S, et al. ",Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery, Thrombosis and Haemostasis ,1992,67,    ,['citation-journal']," Koppenhagen K, Adolf J, Matthes M, Tröster E, Roder JD, Hass S, et al. Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery.  Thrombosis and Haemostasis 1992;67(6):627‐30. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1055/s-0038-1648513', 'https://www.ncbi.nlm.nih.gov/pubmed/1324534', 'https://scholar.google.com/scholar_lookup?title=Low+molecular+weight+heparin+and+prevention+of+postoperative+thrombosis+in+abdominal+surgery+&author=K+Koppenhagen&author=J+Adolf&author=M+Matthes&author=E+Tröster&author=JD+Roder&author=S+Hass&publication_year=1992&hl=en']",1324534,https://doi.org/10.1055/s-0038-1648513, Koppenhagen 1992 {published data only}  ,excluded,CD006468-bbs2-0054, Not the population of interest (participants without CVC) 
CD006468-bib-0076,"Larocca A, Cavallo F, Bringhen S, Raimondo FD, Falanga A, Evangelista A. ",Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide, Blood ,2012,119,    ,['citation-journal']," Larocca A, Cavallo F, Bringhen S, Raimondo FD, Falanga A, Evangelista A. Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.  Blood 2012;119:933‐9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1182/blood-2011-03-344333', 'https://www.ncbi.nlm.nih.gov/pubmed/21835953', 'https://scholar.google.com/scholar_lookup?title=Aspirin+or+enoxaparin+thromboprophylaxis+for+patients+with+newly+diagnosed+multiple+myeloma+treated+with+lenalidomide+&author=A+Larocca&author=F+Cavallo&author=S+Bringhen&author=FD+Raimondo&author=A+Falanga&author=A+Evangelista&publication_year=2012&hl=en']",21835953,https://doi.org/10.1182/blood-2011-03-344333, Larocca 2012 {published data only}  ,excluded,CD006468-bbs2-0055, Not the population of interest (participants without CVC) 
CD006468-bib-0078,Bauersachs R. ,Catch‐a randomised clinical trial comparing long‐term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients, Hematology Reports ,2011,3,    ,['citation-journal'], Bauersachs R. Catch‐a randomised clinical trial comparing long‐term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients.  Hematology Reports 2011;3(Suppl 1):13. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Catch‐a+randomised+clinical+trial+comparing+long‐term+tinzaparin+versus+warfarin+for+treatment+of+acute+venous+thromboembolism+in+cancer+patients+&author=R+Bauersachs&publication_year=2011&hl=en']",,, Lee 2015 (CATCH) {published data only}  ,excluded,CD006468-bbs2-0056, Not the population of interest (participants with cancer with VTE); included 9 reports 
CD006468-bib-0077,"Bauersachs R, Lee AY, Kamphuisen PW, Meyer G, Janas MS, Jarner MF, et al. ",Long‐term tinzaparin versus warfarin for treatment of venous thromboembolism (VTE) in cancer patients‐analysis of renal impairment (RI) in the catch study, Journal of Thrombosis and Thrombolysis ,2015,13,    ,['citation-journal']," Bauersachs R, Lee AY, Kamphuisen PW, Meyer G, Janas MS, Jarner MF, et al. Long‐term tinzaparin versus warfarin for treatment of venous thromboembolism (VTE) in cancer patients‐analysis of renal impairment (RI) in the catch study.  Journal of Thrombosis and Thrombolysis 2015;13:76. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Long‐term+tinzaparin+versus+warfarin+for+treatment+of+venous+thromboembolism+(VTE)+in+cancer+patients‐analysis+of+renal+impairment+(RI)+in+the+catch+study+&author=R+Bauersachs&author=AY+Lee&author=PW+Kamphuisen&author=G+Meyer&author=MS+Janas&author=MF+Jarner&publication_year=2015&hl=en']",,, Lee 2015 (CATCH) {published data only}  ,excluded,CD006468-bbs2-0056, Not the population of interest (participants with cancer with VTE); included 9 reports 
CD006468-bib-0079,"Kamphuisen PW, Lee AY, Meyer G, Bauersachs R, Janas MS, Jarner MF, et al. ",Characteristics and risk factors of major and clinically relevant non‐major bleeding in cancer patients receiving anticoagulant treatment for acute venous thromboembolism ‐ the CATCH study, Journal of Thrombosis and Thrombolysis ,2015,13,    ,['citation-journal']," Kamphuisen PW, Lee AY, Meyer G, Bauersachs R, Janas MS, Jarner MF, et al. Characteristics and risk factors of major and clinically relevant non‐major bleeding in cancer patients receiving anticoagulant treatment for acute venous thromboembolism ‐ the CATCH study.  Journal of Thrombosis and Thrombolysis 2015;13:182‐3. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Characteristics+and+risk+factors+of+major+and+clinically+relevant+non‐major+bleeding+in+cancer+patients+receiving+anticoagulant+treatment+for+acute+venous+thromboembolism+‐+the+CATCH+study+&author=PW+Kamphuisen&author=AY+Lee&author=G+Meyer&author=R+Bauersachs&author=MS+Janas&author=MF+Jarner&publication_year=2015&hl=en']",,, Lee 2015 (CATCH) {published data only}  ,excluded,CD006468-bbs2-0056, Not the population of interest (participants with cancer with VTE); included 9 reports 
CD006468-bib-0080,"Khorana AA, Bauersachs R, Kamphuisen PW, Meyer G, Janas MS, Jarner MF, et al. ",Clinical predictors of recurrent venous thromboembolism (VTE) in cancer patients from a randomized trial of long‐term tinzaparin versus warfarin for treatment: the CATCH study, Journal of Clinical Oncology Conference ,2015,33,    ,['citation-journal']," Khorana AA, Bauersachs R, Kamphuisen PW, Meyer G, Janas MS, Jarner MF, et al. Clinical predictors of recurrent venous thromboembolism (VTE) in cancer patients from a randomized trial of long‐term tinzaparin versus warfarin for treatment: the CATCH study.  Journal of Clinical Oncology Conference 2015;33(15 Suppl):9621. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1200/jco.2015.33.15_suppl.9621', 'https://scholar.google.com/scholar_lookup?title=Clinical+predictors+of+recurrent+venous+thromboembolism+(VTE)+in+cancer+patients+from+a+randomized+trial+of+long‐term+tinzaparin+versus+warfarin+for+treatment:+the+CATCH+study+&author=AA+Khorana&author=R+Bauersachs&author=PW+Kamphuisen&author=G+Meyer&author=MS+Janas&author=MF+Jarner&publication_year=2015&hl=en']",,https://doi.org/10.1200/jco.2015.33.15_suppl.9621, Lee 2015 (CATCH) {published data only}  ,excluded,CD006468-bbs2-0056, Not the population of interest (participants with cancer with VTE); included 9 reports 
CD006468-bib-0081,"Lee AY, Bauersachs R, Janas MS, Jarner MF, Kamphuisen PW, Meyer G, et al. ",CATCH: a randomised clinical trial comparing long‐term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients, BMC Cancer ,2013,13,    ,['citation-journal']," Lee AY, Bauersachs R, Janas MS, Jarner MF, Kamphuisen PW, Meyer G, et al. CATCH: a randomised clinical trial comparing long‐term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients.  BMC Cancer 2013;13(1):284. [NCT01130025]CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1186/1471-2407-13-284', 'https://www.ncbi.nlm.nih.gov/pubmed/23764005', 'https://scholar.google.com/scholar_lookup?title=CATCH:+a+randomised+clinical+trial+comparing+long‐term+tinzaparin+versus+warfarin+for+treatment+of+acute+venous+thromboembolism+in+cancer+patients+&author=AY+Lee&author=R+Bauersachs&author=MS+Janas&author=MF+Jarner&author=PW+Kamphuisen&author=G+Meyer&publication_year=2013&hl=en']",23764005,https://doi.org/10.1186/1471-2407-13-284, Lee 2015 (CATCH) {published data only}  ,excluded,CD006468-bbs2-0056, Not the population of interest (participants with cancer with VTE); included 9 reports 
CD006468-bib-0082,"Lee AY, Bauersachs R, Janas MS, Jarner MF, Kamphuisen PW, Meyer G, et al. ",CATCH: a randomized trial comparing tinzaparin versus warfarin for treatment of acute venous thromboembolism (VTE) in cancer patients. ASCO Annual Meeting, Journal of Clinical Oncology ,2012,Suppl,    ,['citation-journal']," Lee AY, Bauersachs R, Janas MS, Jarner MF, Kamphuisen PW, Meyer G, et al. CATCH: a randomized trial comparing tinzaparin versus warfarin for treatment of acute venous thromboembolism (VTE) in cancer patients. ASCO Annual Meeting.  Journal of Clinical Oncology 2012;Suppl:TPS9149. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1200/jco.2012.30.15_suppl.tps9149', 'https://scholar.google.com/scholar_lookup?title=CATCH:+a+randomized+trial+comparing+tinzaparin+versus+warfarin+for+treatment+of+acute+venous+thromboembolism+(VTE)+in+cancer+patients.+ASCO+Annual+Meeting+&author=AY+Lee&author=R+Bauersachs&author=MS+Janas&author=MF+Jarner&author=PW+Kamphuisen&author=G+Meyer&publication_year=2012&hl=en']",,https://doi.org/10.1200/jco.2012.30.15_suppl.tps9149, Lee 2015 (CATCH) {published data only}  ,excluded,CD006468-bbs2-0056, Not the population of interest (participants with cancer with VTE); included 9 reports 
CD006468-bib-0084,"Lee AY, Kamphuisen PW, Meyer G, Bauersachs R, Janas MS, Jarner MF. ",Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial, JAMA ,2015,314,    ,['citation-journal']," Lee AY, Kamphuisen PW, Meyer G, Bauersachs R, Janas MS, Jarner MF. Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial.  JAMA 2015;314:677. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1001/jama.2015.9243', 'https://www.ncbi.nlm.nih.gov/pubmed/26284719', 'https://scholar.google.com/scholar_lookup?title=Tinzaparin+vs+warfarin+for+treatment+of+acute+venous+thromboembolism+in+patients+with+active+cancer:+a+randomized+clinical+trial+&author=AY+Lee&author=PW+Kamphuisen&author=G+Meyer&author=R+Bauersachs&author=MS+Janas&author=MF+Jarner&publication_year=2015&hl=en']",26284719,https://doi.org/10.1001/jama.2015.9243, Lee 2015 (CATCH) {published data only}  ,excluded,CD006468-bbs2-0056, Not the population of interest (participants with cancer with VTE); included 9 reports 
CD006468-bib-0083,"Lee AY, Kamphuisen PW, Meyer G, Bauersachs R, Janas MS, Jarner MF, et al. ","A randomized trial of long‐term tinzaparin, a low molecular weight heparin (LMWH), versus warfarin for treatment of acute venous thromboembolism (VTE) in cancer patients ‐ the CATCH study", Blood ,2014,124,    ,['citation-journal']," Lee AY, Kamphuisen PW, Meyer G, Bauersachs R, Janas MS, Jarner MF, et al. A randomized trial of long‐term tinzaparin, a low molecular weight heparin (LMWH), versus warfarin for treatment of acute venous thromboembolism (VTE) in cancer patients ‐ the CATCH study.  Blood 2014;124:21. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1182/blood.V124.21.LBA-2.LBA-2', 'https://scholar.google.com/scholar_lookup?title=A+randomized+trial+of+long‐term+tinzaparin,+a+low+molecular+weight+heparin+(LMWH),+versus+warfarin+for+treatment+of+acute+venous+thromboembolism+(VTE)+in+cancer+patients+‐+the+CATCH+study+&author=AY+Lee&author=PW+Kamphuisen&author=G+Meyer&author=R+Bauersachs&author=MS+Janas&author=MF+Jarner&publication_year=2014&hl=en']",,https://doi.org/10.1182/blood.V124.21.LBA-2.LBA-2, Lee 2015 (CATCH) {published data only}  ,excluded,CD006468-bbs2-0056, Not the population of interest (participants with cancer with VTE); included 9 reports 
CD006468-bib-0085,"Lersch C, Kotowa W, Janssen D. ",Thromboembolic prophylaxis with dalteparin‐Na (Fragmin) in oncological patients following port implantations, Tumor Diagnostik und Therapie ,2002,23,    ,['citation-journal']," Lersch C, Kotowa W, Janssen D. Thromboembolic prophylaxis with dalteparin‐Na (Fragmin) in oncological patients following port implantations.  Tumor Diagnostik und Therapie 2002;23(3):104‐10. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1055/s-2002-32656', 'https://scholar.google.com/scholar_lookup?title=Thromboembolic+prophylaxis+with+dalteparin‐Na+(Fragmin)+in+oncological+patients+following+port+implantations+&author=C+Lersch&author=W+Kotowa&author=D+Janssen&publication_year=2002&hl=en']",,https://doi.org/10.1055/s-2002-32656, Lersch 2002 {published data only}  ,excluded,CD006468-bbs2-0057, Not an RCT; observational study 
CD006468-bib-0086,"Levine M, Kakkar AK. ",Catheter‐associated thrombosis: thromboprophylaxis or not?, Journal of Clinical Oncology ,2005,23,    ,['citation-journal']," Levine M, Kakkar AK. Catheter‐associated thrombosis: thromboprophylaxis or not?.  Journal of Clinical Oncology 2005;23(18):4006‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1200/JCO.2005.12.901', 'https://www.ncbi.nlm.nih.gov/pubmed/15767646', 'https://scholar.google.com/scholar_lookup?title=Catheter‐associated+thrombosis:+thromboprophylaxis+or+not?&author=M+Levine&author=AK+Kakkar&publication_year=2005&hl=en']",15767646,https://doi.org/10.1200/JCO.2005.12.901, Levine 2005 {published data only}  ,excluded,CD006468-bbs2-0058, Editorial 
CD006468-bib-0087,"Griffiths GO, Burns S, Noble SI, Macbeth FR, Cohen D, Maughan TS. ",FRAGMATIC: a randomised phase III clinical trial investigating the effect of Fragmin® added to standard therapy in patients with lung cancer, BMC Cancer ,2009,9,    ,['citation-journal']," Griffiths GO, Burns S, Noble SI, Macbeth FR, Cohen D, Maughan TS. FRAGMATIC: a randomised phase III clinical trial investigating the effect of Fragmin® added to standard therapy in patients with lung cancer.  BMC Cancer 2009;9(1):1. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1186/1471-2407-9-355', 'https://www.ncbi.nlm.nih.gov/pubmed/19118499', 'https://scholar.google.com/scholar_lookup?title=FRAGMATIC:+a+randomised+phase+III+clinical+trial+investigating+the+effect+of+Fragmin®+added+to+standard+therapy+in+patients+with+lung+cancer+&author=GO+Griffiths&author=S+Burns&author=SI+Noble&author=FR+Macbeth&author=D+Cohen&author=TS+Maughan&publication_year=2009&hl=en']",19118499,https://doi.org/10.1186/1471-2407-9-355, Macbeth 2016 (FRAGMATIC) {published data only}  ,excluded,CD006468-bbs2-0059, Not the population of interest (participants without CVC); included 4 reports 
CD006468-bib-0088,"Macbeth F, Noble S, Evans J, Ahmed S, Cohen D, Hood K, et al. ",Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial, Journal of Clinical Oncology ,2016,34,    ,['citation-journal']," Macbeth F, Noble S, Evans J, Ahmed S, Cohen D, Hood K, et al. Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial.  Journal of Clinical Oncology 2016;34(5):488‐94. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1200/JCO.2015.64.0268', 'https://www.ncbi.nlm.nih.gov/pubmed/26700124', 'https://scholar.google.com/scholar_lookup?title=Randomized+phase+III+trial+of+standard+therapy+plus+low+molecular+weight+heparin+in+patients+with+lung+cancer:+FRAGMATIC+trial+&author=F+Macbeth&author=S+Noble&author=J+Evans&author=S+Ahmed&author=D+Cohen&author=K+Hood&publication_year=2016&hl=en']",26700124,https://doi.org/10.1200/JCO.2015.64.0268, Macbeth 2016 (FRAGMATIC) {published data only}  ,excluded,CD006468-bbs2-0059, Not the population of interest (participants without CVC); included 4 reports 
CD006468-bib-0089,"Macbeth F, Noble S, Griffiths G, Chowdhury R, Rolfe C, Hood K, et al. ",Preliminary results from the Fragmatic trial: a randomised phase III clinical trial investigating the effect of Fragmin (R) added to standard therapy in patients with lung cancer, Journal of Thoracic Oncology ,2013,8,    ,['citation-journal']," Macbeth F, Noble S, Griffiths G, Chowdhury R, Rolfe C, Hood K, et al. Preliminary results from the Fragmatic trial: a randomised phase III clinical trial investigating the effect of Fragmin (R) added to standard therapy in patients with lung cancer.  Journal of Thoracic Oncology 2013;8:S243. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Preliminary+results+from+the+Fragmatic+trial:+a+randomised+phase+III+clinical+trial+investigating+the+effect+of+Fragmin+(R)+added+to+standard+therapy+in+patients+with+lung+cancer+&author=F+Macbeth&author=S+Noble&author=G+Griffiths&author=R+Chowdhury&author=C+Rolfe&author=K+Hood&publication_year=2013&hl=en']",,, Macbeth 2016 (FRAGMATIC) {published data only}  ,excluded,CD006468-bbs2-0059, Not the population of interest (participants without CVC); included 4 reports 
CD006468-bib-0090,"Noble S, Robbins A, Alikhan R, Hood K, Macbeth F. ",Prediction of venous thromboembolism in lung cancer patients receiving chemotherapy, Journal of Thrombosis and Haemostasis ,2015,13,    ,['citation-journal']," Noble S, Robbins A, Alikhan R, Hood K, Macbeth F. Prediction of venous thromboembolism in lung cancer patients receiving chemotherapy.  Journal of Thrombosis and Haemostasis 2015;13:143. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Prediction+of+venous+thromboembolism+in+lung+cancer+patients+receiving+chemotherapy&author=S+Noble&author=A+Robbins&author=R+Alikhan&author=K+Hood&author=F+Macbeth&publication_year=2015&hl=en']",,, Macbeth 2016 (FRAGMATIC) {published data only}  ,excluded,CD006468-bbs2-0059, Not the population of interest (participants without CVC); included 4 reports 
CD006468-bib-0091,"Magagnoli M, Masci G, Castagna L, Zucali PA, Pedicini V, Bramanti S, et al. ",Retrospective analysis of central venous catheter‐related thrombosis in 427 cancer patients prophylaxed with low‐dose warfarin, Journal of Clinical Oncology ,2004,22,    ,['citation-journal']," Magagnoli M, Masci G, Castagna L, Zucali PA, Pedicini V, Bramanti S, et al. Retrospective analysis of central venous catheter‐related thrombosis in 427 cancer patients prophylaxed with low‐dose warfarin.  Journal of Clinical Oncology 2004;22(14S):8102. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1200/jco.2004.22.90140.8102', 'https://scholar.google.com/scholar_lookup?title=Retrospective+analysis+of+central+venous+catheter‐related+thrombosis+in+427+cancer+patients+prophylaxed+with+low‐dose+warfarin+&author=M+Magagnoli&author=G+Masci&author=L+Castagna&author=PA+Zucali&author=V+Pedicini&author=S+Bramanti&publication_year=2004&hl=en']",,https://doi.org/10.1200/jco.2004.22.90140.8102, Magagnoli 2004 {published data only}  ,excluded,CD006468-bbs2-0060, Not an RCT; retrospective study 
CD006468-bib-0092,"Magagnoli M, Masci G, Castagna L, Zucali PA, Morenghi E, Pedicini V, et al. ",Prophylaxis of central venous catheter‐related thrombosis with minidose warfarin: analysis of its use in 427 cancer patients, Anticancer Research ,2005,25,    ,['citation-journal']," Magagnoli M, Masci G, Castagna L, Zucali PA, Morenghi E, Pedicini V, et al. Prophylaxis of central venous catheter‐related thrombosis with minidose warfarin: analysis of its use in 427 cancer patients.  Anticancer Research 2005;25(4):3143‐7. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/16080578', 'https://scholar.google.com/scholar_lookup?title=Prophylaxis+of+central+venous+catheter‐related+thrombosis+with+minidose+warfarin:+analysis+of+its+use+in+427+cancer+patients+&author=M+Magagnoli&author=G+Masci&author=L+Castagna&author=PA+Zucali&author=E+Morenghi&author=V+Pedicini&publication_year=2005&hl=en']",16080578,, Magagnoli 2005 {published data only}  ,excluded,CD006468-bbs2-0061, Not an RCT; no control group 
CD006468-bib-0093,"Maxwell GL, Synan I, Dodge R, Carroll B, Clarke‐Pearson DL. ",Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial, American College of Obstetricians and Gynecologists ,2001,98,    ,['citation-journal']," Maxwell GL, Synan I, Dodge R, Carroll B, Clarke‐Pearson DL. Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial.  American College of Obstetricians and Gynecologists 2001;98(6):989‐95. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00006250-200112000-00002', 'https://scholar.google.com/scholar_lookup?title=Pneumatic+compression+versus+low+molecular+weight+heparin+in+gynecologic+oncology+surgery:+a+randomized+trial+&author=GL+Maxwell&author=I+Synan&author=R+Dodge&author=B+Carroll&author=DL+Clarke‐Pearson&publication_year=2001&hl=en']",,https://doi.org/10.1097/00006250-200112000-00002, Maxwell 2001 {published data only}  ,excluded,CD006468-bbs2-0062, Not the population of interest (participants without CVC) 
CD006468-bib-0094,"Mazilu L, Parepa IR, Suceveanu AI, Suceveanu A, Baz R, Catrinoiu D. ",Venous thromboembolism: secondary prevention with dabigatran vs. acenocumarol in patients with paraneoplastic deep vein thrombosis. Results from a small prospective study in Romania, Cardiovascular Research ,2014,103,    ,['citation-journal']," Mazilu L, Parepa IR, Suceveanu AI, Suceveanu A, Baz R, Catrinoiu D. Venous thromboembolism: secondary prevention with dabigatran vs. acenocumarol in patients with paraneoplastic deep vein thrombosis. Results from a small prospective study in Romania.  Cardiovascular Research 2014;103(Suppl 1):S39, P221. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1093/cvr/cvu082.154', 'https://scholar.google.com/scholar_lookup?title=Venous+thromboembolism:+secondary+prevention+with+dabigatran+vs.+acenocumarol+in+patients+with+paraneoplastic+deep+vein+thrombosis.+Results+from+a+small+prospective+study+in+Romania+&author=L+Mazilu&author=IR+Parepa&author=AI+Suceveanu&author=A+Suceveanu&author=R+Baz&author=D+Catrinoiu&publication_year=2014&hl=en']",,https://doi.org/10.1093/cvr/cvu082.154, Mazilu 2014 (OVIDIUS) {published data only}  ,excluded,CD006468-bbs2-0063, Not the population of interest (participants with cancer with VTE) 
CD006468-bib-0095,"Murakami M, Wiley LA, Cindrick‐Pounds L, Hunter GC, Uchida T, Killewich LA. ",External pneumatic compression does not increase urokinase plasminogen activator after abdominal surgery, Journal of Vascular Surgery ,2002,36,    ,['citation-journal']," Murakami M, Wiley LA, Cindrick‐Pounds L, Hunter GC, Uchida T, Killewich LA. External pneumatic compression does not increase urokinase plasminogen activator after abdominal surgery.  Journal of Vascular Surgery 2002;36(5):917‐21. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1067/mva.2002.128940', 'https://www.ncbi.nlm.nih.gov/pubmed/12422101', 'https://scholar.google.com/scholar_lookup?title=External+pneumatic+compression+does+not+increase+urokinase+plasminogen+activator+after+abdominal+surgery+&author=M+Murakami&author=LA+Wiley&author=L+Cindrick‐Pounds&author=GC+Hunter&author=T+Uchida&author=LA+Killewich&publication_year=2002&hl=en']",12422101,https://doi.org/10.1067/mva.2002.128940, Murakami 2002 {published data only}  ,excluded,CD006468-bbs2-0064, Not the population of interest (participants without CVC) 
CD006468-bib-0096,"Nagata C, Tanabe H, Takakura S, Narui C, Saito M, Yanaihara N, et al. ",Randomized controlled trial of enoxaparin versus intermittent pneumatic compression for venous thromboembolism prevention in Japanese surgical patients with gynecologic malignancy, Journal of Obstetrics and Gynaecology Research ,2015,41,    ,['citation-journal']," Nagata C, Tanabe H, Takakura S, Narui C, Saito M, Yanaihara N, et al. Randomized controlled trial of enoxaparin versus intermittent pneumatic compression for venous thromboembolism prevention in Japanese surgical patients with gynecologic malignancy.  Journal of Obstetrics and Gynaecology Research 2015;41(9):1440‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/jog.12740', 'https://www.ncbi.nlm.nih.gov/pubmed/26111609', 'https://scholar.google.com/scholar_lookup?title=Randomized+controlled+trial+of+enoxaparin+versus+intermittent+pneumatic+compression+for+venous+thromboembolism+prevention+in+Japanese+surgical+patients+with+gynecologic+malignancy+&author=C+Nagata&author=H+Tanabe&author=S+Takakura&author=C+Narui&author=M+Saito&author=N+Yanaihara&publication_year=2015&hl=en']",26111609,https://doi.org/10.1111/jog.12740, Nagata 2015 {published data only}  ,excluded,CD006468-bbs2-0065, Not the population of interest (participants without CVC) 
CD006468-bib-0097,"Nurmohamed MT, van Riel AM, Henkens CM, Koopman MM, Que GT, d'Azemar P, et al. ",Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery, Thrombosis Haemostasis ,1996,75,    ,['citation-journal']," Nurmohamed MT, van Riel AM, Henkens CM, Koopman MM, Que GT, d'Azemar P, et al. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery.  Thrombosis Haemostasis 1996;75:233‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1055/s-0038-1650250', 'https://www.ncbi.nlm.nih.gov/pubmed/8815566', ""https://scholar.google.com/scholar_lookup?title=Low+molecular+weight+heparin+and+compression+stockings+in+the+prevention+of+venous+thromboembolism+in+neurosurgery+&author=MT+Nurmohamed&author=AM+Riel&author=CM+Henkens&author=MM+Koopman&author=GT+Que&author=P+d'Azemar&publication_year=1996&hl=en""]",8815566,https://doi.org/10.1055/s-0038-1650250, Nurmohamed 1996 {published data only}  ,excluded,CD006468-bbs2-0066, Not the population of interest (participants without CVC) 
CD006468-bib-0098,"Cavo M, Palumbo A, Bringhen S, Di Raimondo F, Patriarca F, Rossi D, et al. ",Phase III study of enoxaparin versus aspirin versus low‐dose warfarin as thromboprophylaxis for patients with newly diagnosed multiple myeloma treated upfront with thalidomide‐containing regimens, Haematologica ,2010,95,    ,['citation-journal']," Cavo M, Palumbo A, Bringhen S, Di Raimondo F, Patriarca F, Rossi D, et al. Phase III study of enoxaparin versus aspirin versus low‐dose warfarin as thromboprophylaxis for patients with newly diagnosed multiple myeloma treated upfront with thalidomide‐containing regimens.  Haematologica 2010;95:391. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Phase+III+study+of+enoxaparin+versus+aspirin+versus+low‐dose+warfarin+as+thromboprophylaxis+for+patients+with+newly+diagnosed+multiple+myeloma+treated+upfront+with+thalidomide‐containing+regimens+&author=M+Cavo&author=A+Palumbo&author=S+Bringhen&author=F+Raimondo&author=F+Patriarca&author=D+Rossi&publication_year=2010&hl=en']",,, Palumbo 2011 {published data only}  ,excluded,CD006468-bbs2-0067, Not the population of interest (participants without CVC) 
CD006468-bib-0099,"Cavo M, Palumbo A, Bringhen S, Falcone A, Musto P, Ciceri F, et al. ",A phase III study of enoxaparin versus low‐dose warfarin versus aspirin as thromboprophylaxis for patients with newly diagnosed multiple myeloma treated up‐front with thalidomide‐containing regimens, Blood ,2008,112,    ,['citation-journal']," Cavo M, Palumbo A, Bringhen S, Falcone A, Musto P, Ciceri F, et al. A phase III study of enoxaparin versus low‐dose warfarin versus aspirin as thromboprophylaxis for patients with newly diagnosed multiple myeloma treated up‐front with thalidomide‐containing regimens.  Blood 2008;112(11):3017. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1182/blood.V112.11.3017.3017', 'https://scholar.google.com/scholar_lookup?title=A+phase+III+study+of+enoxaparin+versus+low‐dose+warfarin+versus+aspirin+as+thromboprophylaxis+for+patients+with+newly+diagnosed+multiple+myeloma+treated+up‐front+with+thalidomide‐containing+regimens+&author=M+Cavo&author=A+Palumbo&author=S+Bringhen&author=A+Falcone&author=P+Musto&author=F+Ciceri&publication_year=2008&hl=en']",,https://doi.org/10.1182/blood.V112.11.3017.3017, Palumbo 2011 {published data only}  ,excluded,CD006468-bbs2-0067, Not the population of interest (participants without CVC) 
CD006468-bib-0100,"Cavo M, Palumbo A, Bringhen S, Falcone A, Musto P, Ciceri F, et al. ",A phase III study of enoxaparin versus low‐dose warfarin versus aspirin as thromboprophylaxis for patients with newly diagnosed multiple myeloma treated up‐front with thalidomide‐containing regimens, Haematologica ,2009,94,    ,['citation-journal']," Cavo M, Palumbo A, Bringhen S, Falcone A, Musto P, Ciceri F, et al. A phase III study of enoxaparin versus low‐dose warfarin versus aspirin as thromboprophylaxis for patients with newly diagnosed multiple myeloma treated up‐front with thalidomide‐containing regimens.  Haematologica 2009;94:s4. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+phase+III+study+of+enoxaparin+versus+low‐dose+warfarin+versus+aspirin+as+thromboprophylaxis+for+patients+with+newly+diagnosed+multiple+myeloma+treated+up‐front+with+thalidomide‐containing+regimens+&author=M+Cavo&author=A+Palumbo&author=S+Bringhen&author=A+Falcone&author=P+Musto&author=F+Ciceri&publication_year=2009&hl=en']",,, Palumbo 2011 {published data only}  ,excluded,CD006468-bbs2-0067, Not the population of interest (participants without CVC) 
CD006468-bib-0101,"Magarotto V, Brioli A, Patriarca F, Rossi D, Petrucci MT, Nozzoli C, et al. ","Enoxaparin, aspirin, or warfarin for the thromboprophylaxis in newly diagnosed myeloma patients receiving thalidomide: a randomized controlled trial", XI Congress of the Italian Society of Experimental Hematology ,2010,95,    ,['citation-journal']," Magarotto V, Brioli A, Patriarca F, Rossi D, Petrucci MT, Nozzoli C, et al. Enoxaparin, aspirin, or warfarin for the thromboprophylaxis in newly diagnosed myeloma patients receiving thalidomide: a randomized controlled trial.  XI Congress of the Italian Society of Experimental Hematology 2010;95:S1‐62. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Enoxaparin,+aspirin,+or+warfarin+for+the+thromboprophylaxis+in+newly+diagnosed+myeloma+patients+receiving+thalidomide:+a+randomized+controlled+trial+&author=V+Magarotto&author=A+Brioli&author=F+Patriarca&author=D+Rossi&author=MT+Petrucci&author=C+Nozzoli&publication_year=2010&hl=en']",,, Palumbo 2011 {published data only}  ,excluded,CD006468-bbs2-0067, Not the population of interest (participants without CVC) 
CD006468-bib-0102,"Palumbo A, Cavo M, Bringhen S, Zaccaria A, Spadano A, Palmieri S, et al. ","Enoxaparin versus aspirin versus low‐fixed‐dose of warfarin in newly diagnosed myeloma patients treated with thalidomide‐containing regimens: a randomized, controlled trial [Abstract No. 0910]", Haematologica ,2008,93,    ,['citation-journal']," Palumbo A, Cavo M, Bringhen S, Zaccaria A, Spadano A, Palmieri S, et al. Enoxaparin versus aspirin versus low‐fixed‐dose of warfarin in newly diagnosed myeloma patients treated with thalidomide‐containing regimens: a randomized, controlled trial [Abstract No. 0910].  Haematologica 2008;93:362. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Enoxaparin+versus+aspirin+versus+low‐fixed‐dose+of+warfarin+in+newly+diagnosed+myeloma+patients+treated+with+thalidomide‐containing+regimens:+a+randomized,+controlled+trial+[Abstract+No.+0910]+&author=A+Palumbo&author=M+Cavo&author=S+Bringhen&author=A+Zaccaria&author=A+Spadano&author=S+Palmieri&publication_year=2008&hl=en']",,, Palumbo 2011 {published data only}  ,excluded,CD006468-bbs2-0067, Not the population of interest (participants without CVC) 
CD006468-bib-0103,"Palumbo A, Cavo M, Bringhen S, Zamagni E, Romano A, Patriarca F, et al. ","Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open‐label, randomized trial", Journal of Clinical Oncology ,2011,29,    ,['citation-journal']," Palumbo A, Cavo M, Bringhen S, Zamagni E, Romano A, Patriarca F, et al. Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open‐label, randomized trial.  Journal of Clinical Oncology 2011;29:986‐93. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1200/JCO.2010.31.6844', 'https://www.ncbi.nlm.nih.gov/pubmed/21282540', 'https://scholar.google.com/scholar_lookup?title=Aspirin,+warfarin,+or+enoxaparin+thromboprophylaxis+in+patients+with+multiple+myeloma+treated+with+thalidomide:+a+phase+III,+open‐label,+randomized+trial+&author=A+Palumbo&author=M+Cavo&author=S+Bringhen&author=E+Zamagni&author=A+Romano&author=F+Patriarca&publication_year=2011&hl=en']",21282540,https://doi.org/10.1200/JCO.2010.31.6844, Palumbo 2011 {published data only}  ,excluded,CD006468-bbs2-0067, Not the population of interest (participants without CVC) 
CD006468-bib-0104,"Park K, Oh SY, Kim WS, Jeong HS, Lee JT, Kong K, et al. ",Randomized phase III trial of very low dose warfarin to prevent catheter‐associated thrombosis,,1999,,    ,['citation-other']," Park K, Oh SY, Kim WS, Jeong HS, Lee JT, Kong K, et al. Randomized phase III trial of very low dose warfarin to prevent catheter‐associated thrombosis. American Society of Clinical Oncology1999:2330. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Randomized+phase+III+trial+of+very+low+dose+warfarin+to+prevent+catheter‐associated+thrombosis+&author=K+Park&author=SY+Oh&author=WS+Kim&author=HS+Jeong&author=JT+Lee&author=K+Kong&publication_year=1999&hl=en']",,, Park 1999 {published data only}  ,excluded,CD006468-bbs2-0068, No obtainable needed data from the authors 
CD006468-bib-0105,"Pelzer U, Deutschinoff G, Opitz B, Stauch M, Reitzig P, Hahnfeld S, et al. ","A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy ‐ first results of the CONKO 004 trial", Onkologie ‐ DGHO meeting ,October 2009,580,    ,['citation-journal']," Pelzer U, Deutschinoff G, Opitz B, Stauch M, Reitzig P, Hahnfeld S, et al. A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy ‐ first results of the CONKO 004 trial.  Onkologie ‐ DGHO meeting October 2009;580:Abstract. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+prospective,+randomized+trial+of+simultaneous+pancreatic+cancer+treatment+with+enoxaparin+and+chemotherapy+‐+first+results+of+the+CONKO+004+trial+&author=U+Pelzer&author=G+Deutschinoff&author=B+Opitz&author=M+Stauch&author=P+Reitzig&author=S+Hahnfeld&publication_year=October2009&hl=en']",,, Pelzer 2015 (CONKO‐004) {published data only}  ,excluded,CD006468-bbs2-0069, Not the population of interest (participants without CVC); included 10 reports 
CD006468-bib-0106,"Pelzer U, Hilbig A, Stieler J, Roll L, Riess H, Dorken B, et al. ","A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy (PROSPECT ‐ CONKO 004)", Onkologie ,2005,28,    ,['citation-journal']," Pelzer U, Hilbig A, Stieler J, Roll L, Riess H, Dorken B, et al. A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy (PROSPECT ‐ CONKO 004).  Onkologie 2005;28(Suppl 3):54 (Abstract 151). CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+prospective,+randomized+trial+of+simultaneous+pancreatic+cancer+treatment+with+enoxaparin+and+chemotherapy+(PROSPECT+‐+CONKO+004)+&author=U+Pelzer&author=A+Hilbig&author=J+Stieler&author=L+Roll&author=H+Riess&author=B+Dorken&publication_year=2005&hl=en']",,, Pelzer 2015 (CONKO‐004) {published data only}  ,excluded,CD006468-bbs2-0069, Not the population of interest (participants without CVC); included 10 reports 
CD006468-bib-0107,"Pelzer U, Hilbig A, Stieler J, Roll L, Stauch M, Opitz B, et al. ","A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy (PROSPECT‐CONKO 004)", ASCO Annual Meeting Proceedings ,2006,24,    ,['citation-journal']," Pelzer U, Hilbig A, Stieler J, Roll L, Stauch M, Opitz B, et al. A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy (PROSPECT‐CONKO 004).  ASCO Annual Meeting Proceedings 2006;24(18):4110. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1200/jco.2006.24.18_suppl.4110', 'https://scholar.google.com/scholar_lookup?title=A+prospective,+randomized+trial+of+simultaneous+pancreatic+cancer+treatment+with+enoxaparin+and+chemotherapy+(PROSPECT‐CONKO+004)+&author=U+Pelzer&author=A+Hilbig&author=J+Stieler&author=L+Roll&author=M+Stauch&author=B+Opitz&publication_year=2006&hl=en']",,https://doi.org/10.1200/jco.2006.24.18_suppl.4110, Pelzer 2015 (CONKO‐004) {published data only}  ,excluded,CD006468-bbs2-0069, Not the population of interest (participants without CVC); included 10 reports 
CD006468-bib-0108,"Pelzer U, Hilbig A, Stieler JM, Bahra M, Sinn M, Gebauer B, et al. ",Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer ‐ the CONKO 004 pilot trial, BMC Cancer ,2014,14,    ,['citation-journal']," Pelzer U, Hilbig A, Stieler JM, Bahra M, Sinn M, Gebauer B, et al. Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer ‐ the CONKO 004 pilot trial.  BMC Cancer 2014;14:204. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1186/1471-2407-14-204', 'https://www.ncbi.nlm.nih.gov/pubmed/24641937', 'https://scholar.google.com/scholar_lookup?title=Intensified+chemotherapy+and+simultaneous+treatment+with+heparin+in+outpatients+with+pancreatic+cancer+‐+the+CONKO+004+pilot+trial+&author=U+Pelzer&author=A+Hilbig&author=JM+Stieler&author=M+Bahra&author=M+Sinn&author=B+Gebauer&publication_year=2014&hl=en']",24641937,https://doi.org/10.1186/1471-2407-14-204, Pelzer 2015 (CONKO‐004) {published data only}  ,excluded,CD006468-bbs2-0069, Not the population of interest (participants without CVC); included 10 reports 
CD006468-bib-0109,"Pelzer U, Oettle H, Stauch M, Opitz B, Stieler J, Scholten T, et al. ","Prospective, randomized open trial of enoxaparin in patients with advanced pancreatic cancer undergoing first‐line chemotherapy",,2007,,    ,['citation-other']," Pelzer U, Oettle H, Stauch M, Opitz B, Stieler J, Scholten T, et al. Prospective, randomized open trial of enoxaparin in patients with advanced pancreatic cancer undergoing first‐line chemotherapy. XXIst Congress of the International Society on Thrombosis and Haemostasis; 2007 July 6‐12; Geneva. 2007:P‐T‐488. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Prospective,+randomized+open+trial+of+enoxaparin+in+patients+with+advanced+pancreatic+cancer+undergoing+first‐line+chemotherapy+&author=U+Pelzer&author=H+Oettle&author=M+Stauch&author=B+Opitz&author=J+Stieler&author=T+Scholten&publication_year=2007&hl=en']",,, Pelzer 2015 (CONKO‐004) {published data only}  ,excluded,CD006468-bbs2-0069, Not the population of interest (participants without CVC); included 10 reports 
CD006468-bib-0110,"Pelzer U, Opitz B, Deutschinoff G, Stauch M, Reitzig PC, Hahnfeld S, et al. ",Efficacy of prophylactic low–molecular weight heparin for ambulatory patients with advanced pancreatic cancer: outcomes from the CONKO‐004 Trial, Journal of Clinical Oncology ,2015,33,    ,['citation-journal']," Pelzer U, Opitz B, Deutschinoff G, Stauch M, Reitzig PC, Hahnfeld S, et al. Efficacy of prophylactic low–molecular weight heparin for ambulatory patients with advanced pancreatic cancer: outcomes from the CONKO‐004 Trial.  Journal of Clinical Oncology 2015;33(18):2028‐34. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1200/JCO.2014.55.1481', 'https://www.ncbi.nlm.nih.gov/pubmed/25987694', 'https://scholar.google.com/scholar_lookup?title=Efficacy+of+prophylactic+low–molecular+weight+heparin+for+ambulatory+patients+with+advanced+pancreatic+cancer:+outcomes+from+the+CONKO‐004+Trial+&author=U+Pelzer&author=B+Opitz&author=G+Deutschinoff&author=M+Stauch&author=PC+Reitzig&author=S+Hahnfeld&publication_year=2015&hl=en']",25987694,https://doi.org/10.1200/JCO.2014.55.1481, Pelzer 2015 (CONKO‐004) {published data only}  ,excluded,CD006468-bbs2-0069, Not the population of interest (participants without CVC); included 10 reports 
CD006468-bib-0111,"Riess H, Pelzer U, Deutschinoff G, Opitz B, Stauch M, Reitzig P, et al. ","A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): results of the CONKO 004 trial", ASCO Annual Meeting Proceedings ,2009,27,    ,['citation-journal']," Riess H, Pelzer U, Deutschinoff G, Opitz B, Stauch M, Reitzig P, et al. A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): results of the CONKO 004 trial.  ASCO Annual Meeting Proceedings 2009;27(18S):LBA4506. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+prospective,+randomized+trial+of+chemotherapy+with+or+without+the+low+molecular+weight+heparin+(LMWH)+enoxaparin+in+patients+(pts)+with+advanced+pancreatic+cancer+(APC):+results+of+the+CONKO+004+trial+&author=H+Riess&author=U+Pelzer&author=G+Deutschinoff&author=B+Opitz&author=M+Stauch&author=P+Reitzig&publication_year=2009&hl=en']",,, Pelzer 2015 (CONKO‐004) {published data only}  ,excluded,CD006468-bbs2-0069, Not the population of interest (participants without CVC); included 10 reports 
CD006468-bib-0112,"Riess H, Pelzer U, Hilbig A, Stieler J, Opitz B, Scholten T, et al. ","Rationale and design of PROSPECT‐CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy", BMC Cancer ,2008,8,    ,['citation-journal']," Riess H, Pelzer U, Hilbig A, Stieler J, Opitz B, Scholten T, et al. Rationale and design of PROSPECT‐CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy.  BMC Cancer 2008;8:361. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1186/1471-2407-8-361', 'https://www.ncbi.nlm.nih.gov/pubmed/19055847', 'https://scholar.google.com/scholar_lookup?title=Rationale+and+design+of+PROSPECT‐CONKO+004:+a+prospective,+randomized+trial+of+simultaneous+pancreatic+cancer+treatment+with+enoxaparin+and+chemotherapy+&author=H+Riess&author=U+Pelzer&author=A+Hilbig&author=J+Stieler&author=B+Opitz&author=T+Scholten&publication_year=2008&hl=en']",19055847,https://doi.org/10.1186/1471-2407-8-361, Pelzer 2015 (CONKO‐004) {published data only}  ,excluded,CD006468-bbs2-0069, Not the population of interest (participants without CVC); included 10 reports 
CD006468-bib-0113,"Riess H, Pelzer U, Opitz B, Hilbig A, Strauch M, Hahnfeld S, et al. ","Late breaking clinical trial: a prospective, randomized trial of chemotherapy with and without the low molecular weight heparin (LMWH) enoxaparin in advanced pancreatic cancer patients", International Society on Thrombosis and Haemostasis ,2009,7,    ,['citation-journal']," Riess H, Pelzer U, Opitz B, Hilbig A, Strauch M, Hahnfeld S, et al. Late breaking clinical trial: a prospective, randomized trial of chemotherapy with and without the low molecular weight heparin (LMWH) enoxaparin in advanced pancreatic cancer patients.  International Society on Thrombosis and Haemostasis 2009;7(Suppl 2):1‐1204. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Late+breaking+clinical+trial:+a+prospective,+randomized+trial+of+chemotherapy+with+and+without+the+low+molecular+weight+heparin+(LMWH)+enoxaparin+in+advanced+pancreatic+cancer+patients+&author=H+Riess&author=U+Pelzer&author=B+Opitz&author=A+Hilbig&author=M+Strauch&author=S+Hahnfeld&publication_year=2009&hl=en']",,, Pelzer 2015 (CONKO‐004) {published data only}  ,excluded,CD006468-bbs2-0069, Not the population of interest (participants without CVC); included 10 reports 
CD006468-bib-0114,"Riess H, Pelzer U, Opitz B, Stauch M, Reitzig P, Hahnfeld S, et al. ","A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy: final results of the CONKO‐004 trial", Journal of Clinical Oncology Conference ,2010,28,    ,['citation-journal']," Riess H, Pelzer U, Opitz B, Stauch M, Reitzig P, Hahnfeld S, et al. A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy: final results of the CONKO‐004 trial.  Journal of Clinical Oncology Conference 2010;28(15 suppl):4033. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1200/jco.2010.28.15_suppl.4033', 'https://scholar.google.com/scholar_lookup?title=A+prospective,+randomized+trial+of+simultaneous+pancreatic+cancer+treatment+with+enoxaparin+and+chemotherapy:+final+results+of+the+CONKO‐004+trial+&author=H+Riess&author=U+Pelzer&author=B+Opitz&author=M+Stauch&author=P+Reitzig&author=S+Hahnfeld&publication_year=2010&hl=en']",,https://doi.org/10.1200/jco.2010.28.15_suppl.4033, Pelzer 2015 (CONKO‐004) {published data only}  ,excluded,CD006468-bbs2-0069, Not the population of interest (participants without CVC); included 10 reports 
CD006468-bib-0115,"Prins MH, Lensing AW, Brighton TA, Lyons RM, Rehm J, Trajanovic M, et al. ",Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN‐DVT and EINSTEIN‐PE): a pooled subgroup analysis of two randomised controlled trials, Lancet Haematology ,2014,1,    ,['citation-journal']," Prins MH, Lensing AW, Brighton TA, Lyons RM, Rehm J, Trajanovic M, et al. Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN‐DVT and EINSTEIN‐PE): a pooled subgroup analysis of two randomised controlled trials.  Lancet Haematology 2014;1(1):e37‐46. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S2352-3026(14)70018-3', 'https://www.ncbi.nlm.nih.gov/pubmed/27030066', 'https://scholar.google.com/scholar_lookup?title=Oral+rivaroxaban+versus+enoxaparin+with+vitamin+K+antagonist+for+the+treatment+of+symptomatic+venous+thromboembolism+in+patients+with+cancer+(EINSTEIN‐DVT+and+EINSTEIN‐PE):+a+pooled+subgroup+analysis+of+two+randomised+controlled+trials+&author=MH+Prins&author=AW+Lensing&author=TA+Brighton&author=RM+Lyons&author=J+Rehm&author=M+Trajanovic&publication_year=2014&hl=en']",27030066,https://doi.org/10.1016/S2352-3026(14)70018-3, Prins 2014 (EINSTEIN) {published data only}  ,excluded,CD006468-bbs2-0070, Not the population of interest (participants with cancer with VTE); included 2 reports 
CD006468-bib-0116,"Raskob GE, van Es N, Segers A, Angchaisuksiri P, Oh D, Boda Z, et al. ","Edoxaban for venous thromboembolism in patients with cancer: results from a non‐inferiority subgroup analysis of the Hokusai‐VTE randomised, double‐blind, double‐dummy trial", Lancet Haematology ,2016,3,    ,['citation-journal']," Raskob GE, van Es N, Segers A, Angchaisuksiri P, Oh D, Boda Z, et al. Edoxaban for venous thromboembolism in patients with cancer: results from a non‐inferiority subgroup analysis of the Hokusai‐VTE randomised, double‐blind, double‐dummy trial.  Lancet Haematology 2016;3(8):e379‐87. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S2352-3026(16)30057-6', 'https://www.ncbi.nlm.nih.gov/pubmed/27476789', 'https://scholar.google.com/scholar_lookup?title=Edoxaban+for+venous+thromboembolism+in+patients+with+cancer:+results+from+a+non‐inferiority+subgroup+analysis+of+the+Hokusai‐VTE+randomised,+double‐blind,+double‐dummy+trial+&author=GE+Raskob&author=N+Es&author=A+Segers&author=P+Angchaisuksiri&author=D+Oh&author=Z+Boda&publication_year=2016&hl=en']",27476789,https://doi.org/10.1016/S2352-3026(16)30057-6, Raskob 2016 (HOKUSAI) {published data only}  ,excluded,CD006468-bbs2-0071, Not the population of interest (participants with cancer with VTE); included 3 reports 
CD006468-bib-0117,"Ratcliffe M, Broadfoot C, Davidson M, Kelly KF, Greaves M, Ratcliffe M, et al. ","Thrombosis, markers of thrombotic risk, indwelling central venous catheters and antithrombotic prophylaxis using low‐dose warfarin in subjects with malignant disease", Clinical and Laboratory Haematology ,1999,21,    ,['citation-journal']," Ratcliffe M, Broadfoot C, Davidson M, Kelly KF, Greaves M, Ratcliffe M, et al. Thrombosis, markers of thrombotic risk, indwelling central venous catheters and antithrombotic prophylaxis using low‐dose warfarin in subjects with malignant disease.  Clinical and Laboratory Haematology 1999;21(5):353‐7. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1046/j.1365-2257.1999.00250.x', 'https://www.ncbi.nlm.nih.gov/pubmed/10646078', 'https://scholar.google.com/scholar_lookup?title=Thrombosis,+markers+of+thrombotic+risk,+indwelling+central+venous+catheters+and+antithrombotic+prophylaxis+using+low‐dose+warfarin+in+subjects+with+malignant+disease+&author=M+Ratcliffe&author=C+Broadfoot&author=M+Davidson&author=KF+Kelly&author=M+Greaves&author=M+Ratcliffe&publication_year=1999&hl=en']",10646078,https://doi.org/10.1046/j.1365-2257.1999.00250.x, Ratcliffe 1999 {published data only}  ,excluded,CD006468-bbs2-0072, Not an RCT 
CD006468-bib-0118,"Romano G, Tartarone A, Ardito R, Bochicchio A, Capobianco A, Coccaro M, et al. ",The influence of externalised Groshong catheters or subcutaneously implanted ports on normal daily activities of cancer patients, Journal of Clinical Oncology ,2005,23,    ,['citation-journal']," Romano G, Tartarone A, Ardito R, Bochicchio A, Capobianco A, Coccaro M, et al. The influence of externalised Groshong catheters or subcutaneously implanted ports on normal daily activities of cancer patients.  Journal of Clinical Oncology 2005;23(16S):8155. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+influence+of+externalised+Groshong+catheters+or+subcutaneously+implanted+ports+on+normal+daily+activities+of+cancer+patients+&author=G+Romano&author=A+Tartarone&author=R+Ardito&author=A+Bochicchio&author=A+Capobianco&author=M+Coccaro&publication_year=2005&hl=en']",,, Romano 2005 {published data only}  ,excluded,CD006468-bbs2-0073, Not an RCT 
CD006468-bib-0119,"Sakon M, Kobayashi T, Shimazui T. ","Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: results from a multicenter, randomized, open‐label study", Thrombosis Research ,2010,125,    ,['citation-journal']," Sakon M, Kobayashi T, Shimazui T. Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: results from a multicenter, randomized, open‐label study.  Thrombosis Research 2010;125(3):e65‐70. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/j.thromres.2009.09.009', 'https://www.ncbi.nlm.nih.gov/pubmed/19919878', 'https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+of+enoxaparin+in+Japanese+patients+undergoing+curative+abdominal+or+pelvic+cancer+surgery:+results+from+a+multicenter,+randomized,+open‐label+study+&author=M+Sakon&author=T+Kobayashi&author=T+Shimazui&publication_year=2010&hl=en']",19919878,https://doi.org/10.1016/j.thromres.2009.09.009, Sakon 2010 {published data only}  ,excluded,CD006468-bbs2-0074, Not the population of interest (participants without CVC) 
CD006468-bib-0120,"Schulman S, Wahlander K, Lundstrom T, Clason SB, Eriksson H, Investigators TI, et al. ",Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran, New England Journal of Medicine ,2003,349,    ,['citation-journal']," Schulman S, Wahlander K, Lundstrom T, Clason SB, Eriksson H, Investigators TI, et al. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran.  New England Journal of Medicine 2003;349(18):1713‐21. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1056/NEJMoa030104', 'https://www.ncbi.nlm.nih.gov/pubmed/14585939', 'https://scholar.google.com/scholar_lookup?title=Secondary+prevention+of+venous+thromboembolism+with+the+oral+direct+thrombin+inhibitor+ximelagatran+&author=S+Schulman&author=K+Wahlander&author=T+Lundstrom&author=SB+Clason&author=H+Eriksson&publication_year=2003&hl=en']",14585939,https://doi.org/10.1056/NEJMoa030104, Schulman 2003 {published data only}  ,excluded,CD006468-bbs2-0075, Not the population of interest (participants with cancer with VTE) 
CD006468-bib-0121,"Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D, et al. ","Extended use of dabigatran, warfarin, or placebo in venous thromboembolism", New England Journal of Medicine ,2013,368,    ,['citation-journal']," Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D, et al. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.  New England Journal of Medicine 2013;368(8):709‐18. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1056/NEJMoa1113697', 'https://www.ncbi.nlm.nih.gov/pubmed/23425163', 'https://scholar.google.com/scholar_lookup?title=Extended+use+of+dabigatran,+warfarin,+or+placebo+in+venous+thromboembolism&author=S+Schulman&author=C+Kearon&author=AK+Kakkar&author=S+Schellong&author=H+Eriksson&author=D+Baanstra&publication_year=2013&hl=en']",23425163,https://doi.org/10.1056/NEJMoa1113697, Schulman 2013 (RE‐MEDY) {published data only}  ,excluded,CD006468-bbs2-0076, Not the population of interest (participants with cancer with VTE) 
CD006468-bib-0122,"Schulman S, Goldhaber SZ, Kearon C, Kakkar AK, Schellong S, Eriksson H, et al. ",Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer, Thrombosis and Haemostasis ,2015,114,    ,['citation-journal']," Schulman S, Goldhaber SZ, Kearon C, Kakkar AK, Schellong S, Eriksson H, et al. Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer.  Thrombosis and Haemostasis 2015;114(1):150‐7. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/25739680', 'https://scholar.google.com/scholar_lookup?title=Treatment+with+dabigatran+or+warfarin+in+patients+with+venous+thromboembolism+and+cancer+&author=S+Schulman&author=SZ+Goldhaber&author=C+Kearon&author=AK+Kakkar&author=S+Schellong&author=H+Eriksson&publication_year=2015&hl=en']",25739680,, Schulman 2015 (RECOVER) {published data only}  ,excluded,CD006468-bbs2-0077, Not the population of interest (participants with cancer with VTE) 
CD006468-bib-0123,"Solomon B, Moore J, Arthur C, Prince HM, Solomon B, Moore J, et al. ",Lack of efficacy of twice‐weekly urokinase in the prevention of complications associated with Hickman catheters: a multicentre randomised comparison of urokinase versus heparin, European Journal of Cancer ,2001,37,    ,['citation-journal']," Solomon B, Moore J, Arthur C, Prince HM, Solomon B, Moore J, et al. Lack of efficacy of twice‐weekly urokinase in the prevention of complications associated with Hickman catheters: a multicentre randomised comparison of urokinase versus heparin.  European Journal of Cancer 2001;37(18):2379‐84. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0959-8049(01)00320-3', 'https://www.ncbi.nlm.nih.gov/pubmed/11720831', 'https://scholar.google.com/scholar_lookup?title=Lack+of+efficacy+of+twice‐weekly+urokinase+in+the+prevention+of+complications+associated+with+Hickman+catheters:+a+multicentre+randomised+comparison+of+urokinase+versus+heparin+&author=B+Solomon&author=J+Moore&author=C+Arthur&author=HM+Prince&author=B+Solomon&author=J+Moore&publication_year=2001&hl=en']",11720831,https://doi.org/10.1016/S0959-8049(01)00320-3, Solomon 2001 {published data only}  ,excluded,CD006468-bbs2-0078, Inadequate control groups; intervention compared with urokinase 
CD006468-bib-0124,"Song KY, Yoo HM, Kim EY, Kim JI, Yim HW, Jeon HM, et al. ",Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial, Annals of Surgical Oncology ,2014,21,    ,['citation-journal']," Song KY, Yoo HM, Kim EY, Kim JI, Yim HW, Jeon HM, et al. Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial.  Annals of Surgical Oncology 2014;21(13):4232‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1245/s10434-014-3893-1', 'https://www.ncbi.nlm.nih.gov/pubmed/25012265', 'https://scholar.google.com/scholar_lookup?title=Optimal+prophylactic+method+of+venous+thromboembolism+for+gastrectomy+in+Korean+patients:+an+interim+analysis+of+prospective+randomized+trial+&author=KY+Song&author=HM+Yoo&author=EY+Kim&author=JI+Kim&author=HW+Yim&author=HM+Jeon&publication_year=2014&hl=en']",25012265,https://doi.org/10.1245/s10434-014-3893-1, Song 2014 {published data only}  ,excluded,CD006468-bbs2-0079, Not the population of interest (participants with cancer with VTE) 
CD006468-bib-0125,"Tesselaar MET, Ouwerkerk J, Rosendaal FR, Osanto S. ","Prophylaxis with low molecular weight heparin reduces the risk for catheter‐related venous thrombosis in cancer patients in centrally, but not in peripherally, inserted central venous catheters", Journal of Clinical Oncology ,2001,20,    ,['citation-journal']," Tesselaar MET, Ouwerkerk J, Rosendaal FR, Osanto S. Prophylaxis with low molecular weight heparin reduces the risk for catheter‐related venous thrombosis in cancer patients in centrally, but not in peripherally, inserted central venous catheters.  Journal of Clinical Oncology 2001;20:1584. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Prophylaxis+with+low+molecular+weight+heparin+reduces+the+risk+for+catheter‐related+venous+thrombosis+in+cancer+patients+in+centrally,+but+not+in+peripherally,+inserted+central+venous+catheters+&author=MET+Tesselaar&author=J+Ouwerkerk&author=FR+Rosendaal&author=S+Osanto&publication_year=2001&hl=en']",,, Tesselaar 2001 {published data only}  ,excluded,CD006468-bbs2-0080, Not an RCT; retrospective study 
CD006468-bib-0126,"Thürlimann B, Bachmann I. ",Effective prevention of chemotherapy‐induced phlebitis by low‐dose heparin: a prospective randomised trial, Annals of Oncology ,1992,3,    ,['citation-journal']," Thürlimann B, Bachmann I. Effective prevention of chemotherapy‐induced phlebitis by low‐dose heparin: a prospective randomised trial.  Annals of Oncology 1992;3(4):311‐3. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1093/oxfordjournals.annonc.a058188', 'https://www.ncbi.nlm.nih.gov/pubmed/1390306', 'https://scholar.google.com/scholar_lookup?title=Effective+prevention+of+chemotherapy‐induced+phlebitis+by+low‐dose+heparin:+a+prospective+randomised+trial+&author=B+Thürlimann&author=I+Bachmann&publication_year=1992&hl=en']",1390306,https://doi.org/10.1093/oxfordjournals.annonc.a058188, Thürlmann 1992 {published data only}  ,excluded,CD006468-bbs2-0081, Not population of interest (peripheral venous catheter and not CVC) 
CD006468-bib-0127,"Vadhan‐Raj S, Zhou X, Varadhachary GR, Milind J, Fogelman D, Shroff R, et al. ",Randomized controlled trial of dalteparin for primary thromboprophylaxis for venous thromboembolism (VTE) in patients with advanced pancreatic cancer (APC): risk factors predictive of VTE, Blood ,2013,122,    ,['citation-journal']," Vadhan‐Raj S, Zhou X, Varadhachary GR, Milind J, Fogelman D, Shroff R, et al. Randomized controlled trial of dalteparin for primary thromboprophylaxis for venous thromboembolism (VTE) in patients with advanced pancreatic cancer (APC): risk factors predictive of VTE.  Blood 2013;122(21):580. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1182/blood.V122.21.580.580', 'https://www.ncbi.nlm.nih.gov/pubmed/23699602', 'https://scholar.google.com/scholar_lookup?title=Randomized+controlled+trial+of+dalteparin+for+primary+thromboprophylaxis+for+venous+thromboembolism+(VTE)+in+patients+with+advanced+pancreatic+cancer+(APC):+risk+factors+predictive+of+VTE+&author=S+Vadhan‐Raj&author=X+Zhou&author=GR+Varadhachary&author=J+Milind&author=D+Fogelman&author=R+Shroff&publication_year=2013&hl=en']",23699602,https://doi.org/10.1182/blood.V122.21.580.580, Vadhan‐Raj 2013 {published data only}  ,excluded,CD006468-bbs2-0082, Not the population of interest (participants with cancer with VTE) 
CD006468-bib-0128,"van Rooden CJ, Rosendaal FR, Barge RMY, van Oostayen JA, van der Meer FJM, Meinders AE, et al. ",Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler‐ultrasound, British Journal of Haematology ,2003,123,    ,['citation-journal']," van Rooden CJ, Rosendaal FR, Barge RMY, van Oostayen JA, van der Meer FJM, Meinders AE, et al. Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler‐ultrasound.  British Journal of Haematology 2003;123(3):507‐12. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1046/j.1365-2141.2003.04638.x', 'https://www.ncbi.nlm.nih.gov/pubmed/14617015', 'https://scholar.google.com/scholar_lookup?title=Central+venous+catheter+related+thrombosis+in+haematology+patients+and+prediction+of+risk+by+screening+with+Doppler‐ultrasound+&author=CJ+Rooden&author=FR+Rosendaal&author=RMY+Barge&author=JA+Oostayen&author=FJM+Meer&author=AE+Meinders&publication_year=2003&hl=en']",14617015,https://doi.org/10.1046/j.1365-2141.2003.04638.x, van Rooden 2003 {published data only}  ,excluded,CD006468-bbs2-0083, Not an RCT; observational study 
CD006468-bib-0129,"Becattini C, Rondelli F, Vedovati MC, Camporese G, Giustozzi M, Boncompagni M, et al. ",Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer, Haematologica ,2015,100,    ,['citation-journal']," Becattini C, Rondelli F, Vedovati MC, Camporese G, Giustozzi M, Boncompagni M, et al. Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer.  Haematologica 2015;100(1):e35‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.3324/haematol.2014.109843', 'https://www.ncbi.nlm.nih.gov/pubmed/25216684', 'https://scholar.google.com/scholar_lookup?title=Incidence+and+risk+factors+for+venous+thromboembolism+after+laparoscopic+surgery+for+colorectal+cancer+&author=C+Becattini&author=F+Rondelli&author=MC+Vedovati&author=G+Camporese&author=M+Giustozzi&author=M+Boncompagni&publication_year=2015&hl=en']",25216684,https://doi.org/10.3324/haematol.2014.109843, Vedovati 2014 {published data only}  ,excluded,CD006468-bbs2-0084, Not the population of interest (participants with cancer with VTE) 
CD006468-bib-0130,"Becattini C, Vedovati MC, Rondelli F, Boncompagni M, Camporese G, Balzarotti R, et al. ",One week vs. four week heparin prophylaxis after laparoscopic surgery for colorectal cancer. The Pro‐lapspilot feasibility study, International Society on Thrombosis and Haemostasis ,2013,11,    ,['citation-journal']," Becattini C, Vedovati MC, Rondelli F, Boncompagni M, Camporese G, Balzarotti R, et al. One week vs. four week heparin prophylaxis after laparoscopic surgery for colorectal cancer. The Pro‐lapspilot feasibility study.  International Society on Thrombosis and Haemostasis 2013;11(Suppl 3):ATT05, 1‐105. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=One+week+vs.+four+week+heparin+prophylaxis+after+laparoscopic+surgery+for+colorectal+cancer.+The+Pro‐lapspilot+feasibility+study+&author=C+Becattini&author=MC+Vedovati&author=F+Rondelli&author=M+Boncompagni&author=G+Camporese&author=R+Balzarotti&publication_year=2013&hl=en']",,, Vedovati 2014 {published data only}  ,excluded,CD006468-bbs2-0084, Not the population of interest (participants with cancer with VTE) 
CD006468-bib-0131,"Vedovati M, Becattini C, Rondelli F, Boncompagni M, Camporese G, Balzarotti R, et al. ",A randomized study on 1‐week versus 4‐week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer, Annals of Surgery ,2014,259,    ,['citation-journal']," Vedovati M, Becattini C, Rondelli F, Boncompagni M, Camporese G, Balzarotti R, et al. A randomized study on 1‐week versus 4‐week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer.  Annals of Surgery 2014;259(4):665‐9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/SLA.0000000000000340', 'https://www.ncbi.nlm.nih.gov/pubmed/24253138', 'https://scholar.google.com/scholar_lookup?title=A+randomized+study+on+1‐week+versus+4‐week+prophylaxis+for+venous+thromboembolism+after+laparoscopic+surgery+for+colorectal+cancer+&author=M+Vedovati&author=C+Becattini&author=F+Rondelli&author=M+Boncompagni&author=G+Camporese&author=R+Balzarotti&publication_year=2014&hl=en']",24253138,https://doi.org/10.1097/SLA.0000000000000340, Vedovati 2014 {published data only}  ,excluded,CD006468-bbs2-0084, Not the population of interest (participants with cancer with VTE) 
CD006468-bib-0132,"Vedovati MC, Becattini C, Rondelli F, Boncompagni M, Camporese G, Balzarotti R, et al. ",A randomized study on 1 vs. 4 weeks prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer, Journal of Thrombosis and Haemostasis ,2013,11,    ,['citation-journal']," Vedovati MC, Becattini C, Rondelli F, Boncompagni M, Camporese G, Balzarotti R, et al. A randomized study on 1 vs. 4 weeks prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer.  Journal of Thrombosis and Haemostasis 2013;11:214. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+randomized+study+on+1+vs.+4+weeks+prophylaxis+for+venous+thromboembolism+after+laparoscopic+surgery+for+colorectal+cancer+&author=MC+Vedovati&author=C+Becattini&author=F+Rondelli&author=M+Boncompagni&author=G+Camporese&author=R+Balzarotti&publication_year=2013&hl=en']",,, Vedovati 2014 {published data only}  ,excluded,CD006468-bbs2-0084, Not the population of interest (participants with cancer with VTE) 
CD006468-bib-0133,"Ward B, Pradhan S. ",Comparison of low molecular weight heparin (Fragmin) with sodium heparin for prophylaxis against postoperative thrombosis in women undergoing major gynaecological surgery, Australian & New Zealand Journal of Obstetrics & Gynaecology ,1998,38,    ,['citation-journal']," Ward B, Pradhan S. Comparison of low molecular weight heparin (Fragmin) with sodium heparin for prophylaxis against postoperative thrombosis in women undergoing major gynaecological surgery.  Australian & New Zealand Journal of Obstetrics & Gynaecology 1998;38(1):91‐2. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/j.1479-828X.1998.tb02968.x', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+low+molecular+weight+heparin+(Fragmin)+with+sodium+heparin+for+prophylaxis+against+postoperative+thrombosis+in+women+undergoing+major+gynaecological+surgery+&author=B+Ward&author=S+Pradhan&publication_year=1998&hl=en']",,https://doi.org/10.1111/j.1479-828X.1998.tb02968.x, Ward 1998 {published data only}  ,excluded,CD006468-bbs2-0085, Not the population of interest (participants with cancer with VTE) 
CD006468-bib-0134,"Wester JW, de Valk HW, Nieuwenhuis HK, Brouwer CB, van der Graaf Y, Meuwissen OJ, et al. ",Risk factors for bleeding during treatment of acute venous thromboembolism, Thrombosis and Haemostasis ,1996,76,    ,['citation-journal']," Wester JW, de Valk HW, Nieuwenhuis HK, Brouwer CB, van der Graaf Y, Meuwissen OJ, et al. Risk factors for bleeding during treatment of acute venous thromboembolism.  Thrombosis and Haemostasis 1996;76(5):682‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1055/s-0038-1650643', 'https://www.ncbi.nlm.nih.gov/pubmed/8950773', 'https://scholar.google.com/scholar_lookup?title=Risk+factors+for+bleeding+during+treatment+of+acute+venous+thromboembolism&author=JW+Wester&author=HW+Valk&author=HK+Nieuwenhuis&author=CB+Brouwer&author=Y+Graaf&author=OJ+Meuwissen&publication_year=1996&hl=en']",8950773,https://doi.org/10.1055/s-0038-1650643, Wester 1996 {published data only}  ,excluded,CD006468-bbs2-0086, Not the population of interest (participants with cancer with VTE); included 2 reports 
CD006468-bib-0135,"de Valk HW, Banga JD, Wester JW, Brouwer CB, van Hessen MW, Meuwissen OJ, et al. ",Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism: a randomized controlled trial, Annals of Internal Medicine ,1995,123,    ,['citation-journal']," de Valk HW, Banga JD, Wester JW, Brouwer CB, van Hessen MW, Meuwissen OJ, et al. Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism: a randomized controlled trial.  Annals of Internal Medicine 1995;123(1):1‐9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.7326/0003-4819-123-1-199507010-00001', 'https://www.ncbi.nlm.nih.gov/pubmed/7539233', 'https://scholar.google.com/scholar_lookup?title=Comparing+subcutaneous+danaparoid+with+intravenous+unfractionated+heparin+for+the+treatment+of+venous+thromboembolism:+a+randomized+controlled+trial+&author=HW+Valk&author=JD+Banga&author=JW+Wester&author=CB+Brouwer&author=MW+Hessen&author=OJ+Meuwissen&publication_year=1995&hl=en']",7539233,https://doi.org/10.7326/0003-4819-123-1-199507010-00001, Wester 1996 {published data only}  ,excluded,CD006468-bbs2-0086, Not the population of interest (participants with cancer with VTE); included 2 reports 
CD006468-bib-0136,"Zheng H, Gao Y, Yan X, Gao M, Gao W. ",Prophylactic use of low molecular weight heparin in combination with graduated compression stockings in post‐operative patients with gynecologic cancer, Zhonghua Zhong Liu za Zhi [Chinese Journal of Oncology] ,2014,36,    ,['citation-journal']," Zheng H, Gao Y, Yan X, Gao M, Gao W. Prophylactic use of low molecular weight heparin in combination with graduated compression stockings in post‐operative patients with gynecologic cancer.  Zhonghua Zhong Liu za Zhi [Chinese Journal of Oncology] 2014;36(1):39‐42. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/24685085', 'https://scholar.google.com/scholar_lookup?title=Prophylactic+use+of+low+molecular+weight+heparin+in+combination+with+graduated+compression+stockings+in+post‐operative+patients+with+gynecologic+cancer+&author=H+Zheng&author=Y+Gao&author=X+Yan&author=M+Gao&author=W+Gao&publication_year=2014&hl=en']",24685085,, Zheng 2014 {published data only}  ,excluded,CD006468-bbs2-0087, Not the population of interest (participants with cancer with VTE) 
CD006468-bib-0137,"Zwicker J, Liebman HA, Bauer KA, Caughey T, Rosovsky R, Mantha S, et al. ",A randomized‐controlled phase II trial of primary thromboprophylaxis with enoxaparin in cancer patients with elevated tissue factor bearing microparticles (the MICROTEC study), Journal of Thrombosis and Haemostasis ,2013,11,    ,['citation-journal']," Zwicker J, Liebman HA, Bauer KA, Caughey T, Rosovsky R, Mantha S, et al. A randomized‐controlled phase II trial of primary thromboprophylaxis with enoxaparin in cancer patients with elevated tissue factor bearing microparticles (the MICROTEC study).  Journal of Thrombosis and Haemostasis 2013;11:6. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+randomized‐controlled+phase+II+trial+of+primary+thromboprophylaxis+with+enoxaparin+in+cancer+patients+with+elevated+tissue+factor+bearing+microparticles+(the+MICROTEC+study)+&author=J+Zwicker&author=HA+Liebman&author=KA+Bauer&author=T+Caughey&author=R+Rosovsky&author=S+Mantha&publication_year=2013&hl=en']",,, Zwicker 2013 (MICRO TEC) {published data only}  ,excluded,CD006468-bbs2-0088, Not the population of interest (participants with cancer with VTE); included 2 reports 
CD006468-bib-0138,"Zwicker JI, Liebman HA, Bauer KA, Caughey T, Campigotto F, Rosovsky R, et al. ",Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor‐bearing microparticles: a randomized‐controlled phase II trial (the Microtec study), British Journal of Haematology ,2013,160,    ,['citation-journal']," Zwicker JI, Liebman HA, Bauer KA, Caughey T, Campigotto F, Rosovsky R, et al. Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor‐bearing microparticles: a randomized‐controlled phase II trial (the Microtec study).  British Journal of Haematology 2013;160(4):530‐7. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/bjh.12163', 'https://www.ncbi.nlm.nih.gov/pubmed/23240761', 'https://scholar.google.com/scholar_lookup?title=Prediction+and+prevention+of+thromboembolic+events+with+enoxaparin+in+cancer+patients+with+elevated+tissue+factor‐bearing+microparticles:+a+randomized‐controlled+phase+II+trial+(the+Microtec+study)+&author=JI+Zwicker&author=HA+Liebman&author=KA+Bauer&author=T+Caughey&author=F+Campigotto&author=R+Rosovsky&publication_year=2013&hl=en']",23240761,https://doi.org/10.1111/bjh.12163, Zwicker 2013 (MICRO TEC) {published data only}  ,excluded,CD006468-bbs2-0088, Not the population of interest (participants with cancer with VTE); included 2 reports 
CD006468-bib-0139,"Agnelli G, Verso M. ",Thrombosis and cancer: clinical relevance of a dangerous liaison, Haematologica ,2005,90,    ,['citation-journal']," Agnelli G, Verso M. Thrombosis and cancer: clinical relevance of a dangerous liaison.  Haematologica 2005;90(2):154‐6.    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/15710565', 'https://scholar.google.com/scholar_lookup?title=Thrombosis+and+cancer:+clinical+relevance+of+a+dangerous+liaison&author=G+Agnelli&author=M+Verso&publication_year=2005&hl=en']",15710565,, Agnelli 2005a ,additional,CD006468-bbs2-0089,
CD006468-bib-0140,"Akl EA, Johnston BC, Alonso‐Coello P, Neumann I, Ebrahim S, Briel M, et al. ",Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers, PloS One ,2013,8,    ,['citation-journal']," Akl EA, Johnston BC, Alonso‐Coello P, Neumann I, Ebrahim S, Briel M, et al. Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers.  PloS One 2013;8(2):e57132.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1371/journal.pone.0057132', 'https://www.ncbi.nlm.nih.gov/pubmed/23451162', 'https://scholar.google.com/scholar_lookup?title=Addressing+dichotomous+data+for+participants+excluded+from+trial+analysis:+a+guide+for+systematic+reviewers+&author=EA+Akl&author=BC+Johnston&author=P+Alonso‐Coello&author=I+Neumann&author=S+Ebrahim&author=M+Briel&publication_year=2013&hl=en']",23451162,https://doi.org/10.1371/journal.pone.0057132, Akl 2013 ,additional,CD006468-bbs2-0090,
CD006468-bib-0141,"Akl EA, Kahale LA, Ebrahim S, Alonso‐Coello P, Schünemann HJ, Guyatt GH. ","Three challenges described for identifying participants with missing data in trials reports, and potential solutions suggested to systematic reviewers", Journal of Clinical Epidemiology ,2016,76,    ,['citation-journal']," Akl EA, Kahale LA, Ebrahim S, Alonso‐Coello P, Schünemann HJ, Guyatt GH. Three challenges described for identifying participants with missing data in trials reports, and potential solutions suggested to systematic reviewers.  Journal of Clinical Epidemiology 2016;76:147‐54.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2016.02.022', 'https://www.ncbi.nlm.nih.gov/pubmed/26944294', 'https://scholar.google.com/scholar_lookup?title=Three+challenges+described+for+identifying+participants+with+missing+data+in+trials+reports,+and+potential+solutions+suggested+to+systematic+reviewers+&author=EA+Akl&author=LA+Kahale&author=S+Ebrahim&author=P+Alonso‐Coello&author=HJ+Schünemann&author=GH+Guyatt&publication_year=2016&hl=en']",26944294,https://doi.org/10.1016/j.jclinepi.2016.02.022, Akl 2016 ,additional,CD006468-bbs2-0091,
CD006468-bib-0142,"Alshurafa M, Briel M, Akl EA, Haines T, Moayyedi P, Gentles SJ, et al. ",Inconsistent definitions for intention‐to‐treat in relation to missing outcome data: systematic review of the methods literature, PloS One ,2012,7,    ,['citation-journal']," Alshurafa M, Briel M, Akl EA, Haines T, Moayyedi P, Gentles SJ, et al. Inconsistent definitions for intention‐to‐treat in relation to missing outcome data: systematic review of the methods literature.  PloS One 2012;7(11):e49163.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1371/journal.pone.0049163', 'https://www.ncbi.nlm.nih.gov/pubmed/23166608', 'https://scholar.google.com/scholar_lookup?title=Inconsistent+definitions+for+intention‐to‐treat+in+relation+to+missing+outcome+data:+systematic+review+of+the+methods+literature+&author=M+Alshurafa&author=M+Briel&author=EA+Akl&author=T+Haines&author=P+Moayyedi&author=SJ+Gentles&publication_year=2012&hl=en']",23166608,https://doi.org/10.1371/journal.pone.0049163, Alshurafa 2012 ,additional,CD006468-bbs2-0092,
CD006468-bib-0143,"Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. ",Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines (8th Edition), Chest ,2008,133,    ,['citation-journal']," Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines (8th Edition).  Chest 2008;133(6 Suppl):160S‐98S.    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/18574265', 'https://scholar.google.com/scholar_lookup?title=Pharmacology+and+management+of+the+vitamin+K+antagonists:+American+College+of+Chest+Physicians+Evidence‐Based+Clinical+Practice+Guidelines+(8th+Edition)+&author=J+Ansell&author=J+Hirsh&author=E+Hylek&author=A+Jacobson&author=M+Crowther&author=G+Palareti&publication_year=2008&hl=en']",18574265,, Ansell 2008 ,additional,CD006468-bbs2-0093,
CD006468-bib-0144,"Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. ",GRADE guidelines: 3. Rating the quality of evidence, Journal of Clinical Epidemiology ,2011,64,    ,['citation-journal']," Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence.  Journal of Clinical Epidemiology 2011;64(4):401‐6.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2010.07.015', 'https://www.ncbi.nlm.nih.gov/pubmed/21208779', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+3.+Rating+the+quality+of+evidence&author=H+Balshem&author=M+Helfand&author=HJ+Schünemann&author=AD+Oxman&author=R+Kunz&author=J+Brozek&publication_year=2011&hl=en']",21208779,https://doi.org/10.1016/j.jclinepi.2010.07.015, Balshem 2011 ,additional,CD006468-bbs2-0094,
CD006468-bib-0145,"Blom JW, Doggen CJ, Osanto S, Rosendaal FR. ","Malignancies, prothrombotic mutations, and the risk of venous thrombosis", JAMA ,2005,293,    ,['citation-journal']," Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis.  JAMA 2005;293(6):715‐22.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1001/jama.293.6.715', 'https://www.ncbi.nlm.nih.gov/pubmed/15701913', 'https://scholar.google.com/scholar_lookup?title=Malignancies,+prothrombotic+mutations,+and+the+risk+of+venous+thrombosis&author=JW+Blom&author=CJ+Doggen&author=S+Osanto&author=FR+Rosendaal&publication_year=2005&hl=en']",15701913,https://doi.org/10.1001/jama.293.6.715, Blom 2005 ,additional,CD006468-bbs2-0095,
CD006468-bib-0146,"Blom JW, Vanderschoot JP, Oostindier MJ, Osanto S, Van der Meer FJ, Rosendaal FR. ",Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study, Journal of Thrombosis and Haemostasis ,2006,4,    ,['citation-journal']," Blom JW, Vanderschoot JP, Oostindier MJ, Osanto S, Van der Meer FJ, Rosendaal FR. Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study.  Journal of Thrombosis and Haemostasis 2006;4(3):529‐35.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/j.1538-7836.2006.01804.x', 'https://www.ncbi.nlm.nih.gov/pubmed/16460435', 'https://scholar.google.com/scholar_lookup?title=Incidence+of+venous+thrombosis+in+a+large+cohort+of+66+329+cancer+patients:+results+of+a+record+linkage+study+&author=JW+Blom&author=JP+Vanderschoot&author=MJ+Oostindier&author=S+Osanto&author=FJ+Meer&author=FR+Rosendaal&publication_year=2006&hl=en']",16460435,https://doi.org/10.1111/j.1538-7836.2006.01804.x, Blom 2006 ,additional,CD006468-bbs2-0096,
CD006468-bib-0147,"Chaukiyal P, Nautiyal A, Radhakrishnan S, Singh S, Navaneethan SD. ",Thromboprophylaxis in cancer patients with central venous catheters: a systematic review and meta‐analysis, Thrombosis and Haemostasis ,2008,99,    ,['citation-journal']," Chaukiyal P, Nautiyal A, Radhakrishnan S, Singh S, Navaneethan SD. Thromboprophylaxis in cancer patients with central venous catheters: a systematic review and meta‐analysis.  Thrombosis and Haemostasis 2008;99:38‐43.    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/18217132', 'https://scholar.google.com/scholar_lookup?title=Thromboprophylaxis+in+cancer+patients+with+central+venous+catheters:+a+systematic+review+and+meta‐analysis+&author=P+Chaukiyal&author=A+Nautiyal&author=S+Radhakrishnan&author=S+Singh&author=SD+Navaneethan&publication_year=2008&hl=en']",18217132,, Chaukiyal 2008 ,additional,CD006468-bbs2-0097,
CD006468-bib-0148,"Deeks JJ, Altman DG, Bradburn MJ. ",Statistical methods for examining heterogeneity and combining results from several studies in meta‐analysis,Systematic Reviews in Health Care: Meta‐Analysis in Context,2001,,    ,['citation-book']," Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta‐analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care: Meta‐Analysis in Context. 2nd Edition. London: BMJ Publication Group, 2001.    Link to article     Google Scholar     ","['https://doi.org/10.1002/9780470693926.ch15', 'https://scholar.google.com/scholar_lookup?title=Statistical+methods+for+examining+heterogeneity+and+combining+results+from+several+studies+in+meta‐analysis+&author=JJ+Deeks&author=DG+Altman&author=MJ+Bradburn&publication_year=2001&hl=en']",,https://doi.org/10.1002/9780470693926.ch15, Deeks 2001 ,additional,CD006468-bbs2-0098,
CD006468-bib-0149,"DerSimonian R, Laird N. ",Meta‐analysis in clinical trials, Controlled Clinical Trials ,1986,7,    ,['citation-journal']," DerSimonian R, Laird N. Meta‐analysis in clinical trials.  Controlled Clinical Trials 1986;7:177‐88.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/0197-2456(86)90046-2', 'https://www.ncbi.nlm.nih.gov/pubmed/3802833', 'https://scholar.google.com/scholar_lookup?title=Meta‐analysis+in+clinical+trials&author=R+DerSimonian&author=N+Laird&publication_year=1986&hl=en']",3802833,https://doi.org/10.1016/0197-2456(86)90046-2, DerSimonian 1986 ,additional,CD006468-bbs2-0099,
CD006468-bib-0150,"Ebrahim S, Akl EA, Mustafa RA, Sun X, Walter SD, Heels‐Ansdell D, et al. ",Addressing continuous data for participants excluded from trial analysis: a guide for systematic reviewers, Journal of Clinical Epidemiology ,2013,66,    ,['citation-journal']," Ebrahim S, Akl EA, Mustafa RA, Sun X, Walter SD, Heels‐Ansdell D, et al. Addressing continuous data for participants excluded from trial analysis: a guide for systematic reviewers.  Journal of Clinical Epidemiology 2013;66(9):1014‐21.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2013.03.014', 'https://www.ncbi.nlm.nih.gov/pubmed/23774111', 'https://scholar.google.com/scholar_lookup?title=Addressing+continuous+data+for+participants+excluded+from+trial+analysis:+a+guide+for+systematic+reviewers+&author=S+Ebrahim&author=EA+Akl&author=RA+Mustafa&author=X+Sun&author=SD+Walter&author=D+Heels‐Ansdell&publication_year=2013&hl=en']",23774111,https://doi.org/10.1016/j.jclinepi.2013.03.014, Ebrahim 2013 ,additional,CD006468-bbs2-0100,
CD006468-bib-0151,"Girolami B, Girolami A. ",Heparin‐induced thrombocytopenia: a review, Seminars in Thrombosis and Hemostasis ,2006,32,    ,['citation-journal']," Girolami B, Girolami A. Heparin‐induced thrombocytopenia: a review.  Seminars in Thrombosis and Hemostasis 2006;32(8):803‐9.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1055/s-2006-955463', 'https://www.ncbi.nlm.nih.gov/pubmed/17171593', 'https://scholar.google.com/scholar_lookup?title=Heparin‐induced+thrombocytopenia:+a+review&author=B+Girolami&author=A+Girolami&publication_year=2006&hl=en']",17171593,https://doi.org/10.1055/s-2006-955463, Girolami 2006 ,additional,CD006468-bbs2-0101,
CD006468-bib-0152,"Guy JB, Bertoletti L, Magné N, Rancoule C, Mahé I, Font C, et al. ",Venous thromboembolism in radiation therapy cancer patients: findings from the RIETE registry, Critical Reviews in Oncology/Hematology ,2017,113,    ,['citation-journal']," Guy JB, Bertoletti L, Magné N, Rancoule C, Mahé I, Font C, et al. Venous thromboembolism in radiation therapy cancer patients: findings from the RIETE registry.  Critical Reviews in Oncology/Hematology 2017;113:83‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.critrevonc.2017.03.006', 'https://scholar.google.com/scholar_lookup?title=Venous+thromboembolism+in+radiation+therapy+cancer+patients:+findings+from+the+RIETE+registry+&author=JB+Guy&author=L+Bertoletti&author=N+Magné&author=C+Rancoule&author=I+Mahé&author=C+Font&publication_year=2017&hl=en']",,https://doi.org/10.1016/j.critrevonc.2017.03.006, Guy 2017 ,additional,CD006468-bbs2-0102,
CD006468-bib-0153,"Guyatt GH, Ebrahim S, Alonso‐Coello P, Johnston BC, Mathioudakis AG, Briel M, et al. ",GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence, Journal of Clinical Epidemiology ,2017,87,    ,['citation-journal']," Guyatt GH, Ebrahim S, Alonso‐Coello P, Johnston BC, Mathioudakis AG, Briel M, et al. GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence.  Journal of Clinical Epidemiology 2017;87:14‐22.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2017.05.005', 'https://www.ncbi.nlm.nih.gov/pubmed/28529188', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines+17:+assessing+the+risk+of+bias+associated+with+missing+participant+outcome+data+in+a+body+of+evidence+&author=GH+Guyatt&author=S+Ebrahim&author=P+Alonso‐Coello&author=BC+Johnston&author=AG+Mathioudakis&author=M+Briel&publication_year=2017&hl=en']",28529188,https://doi.org/10.1016/j.jclinepi.2017.05.005, Guyatt 2017 ,additional,CD006468-bbs2-0103,
CD006468-bib-0154,"Higgins JP, Thompson SG, Deeks JJ, Altman DG. ",Measuring inconsistency in meta‐analysis, BMJ ,2003,327,    ,['citation-journal']," Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analysis.  BMJ 2003;327:557‐60.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1136/bmj.327.7414.557', 'https://www.ncbi.nlm.nih.gov/pubmed/12958120', 'https://scholar.google.com/scholar_lookup?title=Measuring+inconsistency+in+meta‐analysis&author=JP+Higgins&author=SG+Thompson&author=JJ+Deeks&author=DG+Altman&publication_year=2003&hl=en']",12958120,https://doi.org/10.1136/bmj.327.7414.557, Higgins 2003 ,additional,CD006468-bbs2-0104,
CD006468-bib-0155,"Higgins JP, Green S, editor(s). ","Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011",,,,. Available from handbook.cochrane.org.   ,['citation-other']," Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.    ",[],,, Higgins 2011 ,additional,CD006468-bbs2-0105,
CD006468-bib-0156,"Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Buller HR. ",Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis, Journal of Clinical Oncology ,2000,18,    ,['citation-journal']," Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Buller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.  Journal of Clinical Oncology 2000;18(17):3078‐83.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1200/JCO.2000.18.17.3078', 'https://www.ncbi.nlm.nih.gov/pubmed/10963635', 'https://scholar.google.com/scholar_lookup?title=Incidence+of+recurrent+thromboembolic+and+bleeding+complications+among+patients+with+venous+thromboembolism+in+relation+to+both+malignancy+and+achieved+international+normalized+ratio:+a+retrospective+analysis+&author=BA+Hutten&author=MH+Prins&author=M+Gent&author=J+Ginsberg&author=JG+Tijssen&author=HR+Buller&publication_year=2000&hl=en']",10963635,https://doi.org/10.1200/JCO.2000.18.17.3078, Hutten 2000 ,additional,CD006468-bbs2-0106,
CD006468-bib-0157,"Kjaergard LL, Villumsen J, Gluud C. ",Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses, Annals of Internal Medicine ,2001,135,    ,['citation-journal']," Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses.  Annals of Internal Medicine 2001;135(11):982‐9.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.7326/0003-4819-135-11-200112040-00010', 'https://www.ncbi.nlm.nih.gov/pubmed/11730399', 'https://scholar.google.com/scholar_lookup?title=Reported+methodologic+quality+and+discrepancies+between+large+and+small+randomized+trials+in+meta‐analyses+&author=LL+Kjaergard&author=J+Villumsen&author=C+Gluud&publication_year=2001&hl=en']",11730399,https://doi.org/10.7326/0003-4819-135-11-200112040-00010, Kjaergard 2001 ,additional,CD006468-bbs2-0107,
CD006468-bib-0158,"Kreuziger LB, Onwuemene O, Kolesar E, Crowther M, Lim W. ",Systematic review of anticoagulant treatment of catheter‐related thrombosis, Thrombosis Research ,2015,136,    ,['citation-journal']," Kreuziger LB, Onwuemene O, Kolesar E, Crowther M, Lim W. Systematic review of anticoagulant treatment of catheter‐related thrombosis.  Thrombosis Research 2015;136(6):1103‐9.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.thromres.2015.08.020', 'https://www.ncbi.nlm.nih.gov/pubmed/26342400', 'https://scholar.google.com/scholar_lookup?title=Systematic+review+of+anticoagulant+treatment+of+catheter‐related+thrombosis&author=LB+Kreuziger&author=O+Onwuemene&author=E+Kolesar&author=M+Crowther&author=W+Lim&publication_year=2015&hl=en']",26342400,https://doi.org/10.1016/j.thromres.2015.08.020, Kreuziger 2015 ,additional,CD006468-bbs2-0108,
CD006468-bib-0159,Kuter DJ. ,Thrombotic complications of central venous catheters in cancer patients, Oncologist ,2004,9,    ,['citation-journal'], Kuter DJ. Thrombotic complications of central venous catheters in cancer patients.  Oncologist 2004;9(2):207‐16.    Link to article     PubMed     Google Scholar     ,"['https://doi.org/10.1634/theoncologist.9-2-207', 'https://www.ncbi.nlm.nih.gov/pubmed/15047925', 'https://scholar.google.com/scholar_lookup?title=Thrombotic+complications+of+central+venous+catheters+in+cancer+patients&author=DJ+Kuter&publication_year=2004&hl=en']",15047925,https://doi.org/10.1634/theoncologist.9-2-207, Kuter 2004 ,additional,CD006468-bbs2-0109,
CD006468-bib-0160,"Lordick F, Hentrich M, Decker T, Hennig M, Pohlmann H, Hartenstein R, et al. ",Ultrasound screening for internal jugular vein thrombosis aids the detection of central venous catheter‐related infections in patients with haemato‐oncological diseases: a prospective observational study, British Journal of Haematology ,2003,120,    ,['citation-journal']," Lordick F, Hentrich M, Decker T, Hennig M, Pohlmann H, Hartenstein R, et al. Ultrasound screening for internal jugular vein thrombosis aids the detection of central venous catheter‐related infections in patients with haemato‐oncological diseases: a prospective observational study.  British Journal of Haematology 2003;120(6):1073‐8.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1046/j.1365-2141.2003.04199.x', 'https://www.ncbi.nlm.nih.gov/pubmed/12648081', 'https://scholar.google.com/scholar_lookup?title=Ultrasound+screening+for+internal+jugular+vein+thrombosis+aids+the+detection+of+central+venous+catheter‐related+infections+in+patients+with+haemato‐oncological+diseases:+a+prospective+observational+study+&author=F+Lordick&author=M+Hentrich&author=T+Decker&author=M+Hennig&author=H+Pohlmann&author=R+Hartenstein&publication_year=2003&hl=en']",12648081,https://doi.org/10.1046/j.1365-2141.2003.04199.x, Lordick 2003 ,additional,CD006468-bbs2-0110,
CD006468-bib-0161,"Montori VM, Devereaux PJ, Adhikari NKJ, Burns KEA, Eggert CH, Briel M, et al. ",Randomized trials stopped early for benefit: a systematic review, JAMA ,2005,294,    ,['citation-journal']," Montori VM, Devereaux PJ, Adhikari NKJ, Burns KEA, Eggert CH, Briel M, et al. Randomized trials stopped early for benefit: a systematic review.  JAMA 2005;294(17):2203‐9.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1001/jama.294.17.2203', 'https://www.ncbi.nlm.nih.gov/pubmed/16264162', 'https://scholar.google.com/scholar_lookup?title=Randomized+trials+stopped+early+for+benefit:+a+systematic+review&author=VM+Montori&author=PJ+Devereaux&author=NKJ+Adhikari&author=KEA+Burns&author=CH+Eggert&author=M+Briel&publication_year=2005&hl=en']",16264162,https://doi.org/10.1001/jama.294.17.2203, Montori 2005 ,additional,CD006468-bbs2-0111,
CD006468-bib-0162,"Motlekar NA, Srivenugopal KS, Wachtel MS, Youan BB. ",Evaluation of the oral bioavailability of low molecular weight heparin formulated with glycyrrhetinic acid as permeation enhancer, Drug Development Research ,2006,67,    ,['citation-journal']," Motlekar NA, Srivenugopal KS, Wachtel MS, Youan BB. Evaluation of the oral bioavailability of low molecular weight heparin formulated with glycyrrhetinic acid as permeation enhancer.  Drug Development Research 2006;67(2):166‐74.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/ddr.20087', 'https://www.ncbi.nlm.nih.gov/pubmed/17710191', 'https://scholar.google.com/scholar_lookup?title=Evaluation+of+the+oral+bioavailability+of+low+molecular+weight+heparin+formulated+with+glycyrrhetinic+acid+as+permeation+enhancer+&author=NA+Motlekar&author=KS+Srivenugopal&author=MS+Wachtel&author=BB+Youan&publication_year=2006&hl=en']",17710191,https://doi.org/10.1002/ddr.20087, Motlekar 2006 ,additional,CD006468-bbs2-0112,
CD006468-bib-0163,"Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, et al. ",Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis, Blood ,2002,100,    ,['citation-journal']," Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.  Blood 2002;100(10):3484‐8.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1182/blood-2002-01-0108', 'https://www.ncbi.nlm.nih.gov/pubmed/12393647', 'https://scholar.google.com/scholar_lookup?title=Recurrent+venous+thromboembolism+and+bleeding+complications+during+anticoagulant+treatment+in+patients+with+cancer+and+venous+thrombosis+&author=P+Prandoni&author=AW+Lensing&author=A+Piccioli&author=E+Bernardi&author=P+Simioni&author=B+Girolami&publication_year=2002&hl=en']",12393647,https://doi.org/10.1182/blood-2002-01-0108, Prandoni 2002 ,additional,CD006468-bbs2-0113,
CD006468-bib-0164,"The Nordic Cochrane Centre, The Cochrane Collaboration. ",Review Manager (RevMan),,2014,,.   ,['citation-other']," The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.    ",[],,, RevMan 2014 [Computer program] ,additional,CD006468-bbs2-0114,
CD006468-bib-0165,"Schoot RA, Kremer LCM, van de Wetering MD, van Ommen CH. ",Systemic treatments for the prevention of venous thrombo‐embolic events in paediatric cancer patients with tunnelled central venous catheters, Cochrane Database of Systematic Reviews ,2013,,    ,['citation-journal']," Schoot RA, Kremer LCM, van de Wetering MD, van Ommen CH. Systemic treatments for the prevention of venous thrombo‐embolic events in paediatric cancer patients with tunnelled central venous catheters.  Cochrane Database of Systematic Reviews 2013, Issue 9. [DOI: 10.1002/14651858.CD009160.pub2]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD009160.pub2', 'https://scholar.google.com/scholar_lookup?title=Systemic+treatments+for+the+prevention+of+venous+thrombo‐embolic+events+in+paediatric+cancer+patients+with+tunnelled+central+venous+catheters+&author=RA+Schoot&author=LCM+Kremer&author=MD+Wetering&author=CH+Ommen&publication_year=2013&hl=en']",,https://doi.org/10.1002/14651858.CD009160.pub2, Schoot 2013 ,additional,CD006468-bbs2-0115,
CD006468-bib-0166,"Smorenburg SM, Van Noorden CJ. ",The complex effects of heparins on cancer progression and metastasis in experimental studies, Pharmacological Review ,2001,53,    ,['citation-journal']," Smorenburg SM, Van Noorden CJ. The complex effects of heparins on cancer progression and metastasis in experimental studies.  Pharmacological Review 2001;53(1):93‐105.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=The+complex+effects+of+heparins+on+cancer+progression+and+metastasis+in+experimental+studies+&author=SM+Smorenburg&author=CJ+Noorden&publication_year=2001&hl=en'],,, Smorenburg 2001 ,additional,CD006468-bbs2-0116,
CD006468-bib-0167,"Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. ",Prognosis of cancers associated with venous thromboembolism, New England Journal of Medicine ,2000,343,    ,['citation-journal']," Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism.  New England Journal of Medicine 2000;343(25):1846‐50.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1056/NEJM200012213432504', 'https://www.ncbi.nlm.nih.gov/pubmed/11117976', 'https://scholar.google.com/scholar_lookup?title=Prognosis+of+cancers+associated+with+venous+thromboembolism&author=HT+Sorensen&author=L+Mellemkjaer&author=JH+Olsen&author=JA+Baron&publication_year=2000&hl=en']",11117976,https://doi.org/10.1056/NEJM200012213432504, Sorensen 2000 ,additional,CD006468-bbs2-0117,
CD006468-bib-0168,"Sutherland DE, Weitz IC, Liebman HA. ","Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment", American Journal of Hematology ,2003,72,    ,['citation-journal']," Sutherland DE, Weitz IC, Liebman HA. Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment.  American Journal of Hematology 2003;72(1):43‐52.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/ajh.10263', 'https://www.ncbi.nlm.nih.gov/pubmed/12508268', 'https://scholar.google.com/scholar_lookup?title=Thromboembolic+complications+of+cancer:+epidemiology,+pathogenesis,+diagnosis,+and+treatment+&author=DE+Sutherland&author=IC+Weitz&author=HA+Liebman&publication_year=2003&hl=en']",12508268,https://doi.org/10.1002/ajh.10263, Sutherland 2003 ,additional,CD006468-bbs2-0118,
CD006468-bib-0169,"Thodiyil P, Kakkar AK. ",Can low‐molecular‐weight heparins improve outcomes in patients with cancer?, Cancer Treatment Reviews ,2002,28,    ,['citation-journal']," Thodiyil P, Kakkar AK. Can low‐molecular‐weight heparins improve outcomes in patients with cancer?.  Cancer Treatment Reviews 2002;28:151‐5.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/S0305-7372(02)00040-3', 'https://www.ncbi.nlm.nih.gov/pubmed/12234567', 'https://scholar.google.com/scholar_lookup?title=Can+low‐molecular‐weight+heparins+improve+outcomes+in+patients+with+cancer?&author=P+Thodiyil&author=AK+Kakkar&publication_year=2002&hl=en']",12234567,https://doi.org/10.1016/S0305-7372(02)00040-3, Thodiyil 2002 ,additional,CD006468-bbs2-0119,
CD006468-bib-0170,"Trikalinos TA, Churchill R, Ferri M, Leucht S, Tuunainen A, Wahlbeck K, et al. ",Effect sizes in cumulative meta‐analyses of mental health randomized trials evolved over time, Journal of Clinical Epidemiology ,2004,57,    ,['citation-journal']," Trikalinos TA, Churchill R, Ferri M, Leucht S, Tuunainen A, Wahlbeck K, et al. Effect sizes in cumulative meta‐analyses of mental health randomized trials evolved over time.  Journal of Clinical Epidemiology 2004;57(11):1124‐30.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2004.02.018', 'https://www.ncbi.nlm.nih.gov/pubmed/15612138', 'https://scholar.google.com/scholar_lookup?title=Effect+sizes+in+cumulative+meta‐analyses+of+mental+health+randomized+trials+evolved+over+time+&author=TA+Trikalinos&author=R+Churchill&author=M+Ferri&author=S+Leucht&author=A+Tuunainen&author=K+Wahlbeck&publication_year=2004&hl=en']",15612138,https://doi.org/10.1016/j.jclinepi.2004.02.018, Trikalinos 2004 ,additional,CD006468-bbs2-0120,
CD006468-bib-0171,"Verso M, Agnelli G. ",Venous thromboembolism associated with long‐term use of central venous catheters in cancer patients, Journal of Clinical Oncology ,2003,21,    ,['citation-journal']," Verso M, Agnelli G. Venous thromboembolism associated with long‐term use of central venous catheters in cancer patients.  Journal of Clinical Oncology 2003;21(19):3665‐75.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1200/JCO.2003.08.008', 'https://www.ncbi.nlm.nih.gov/pubmed/14512399', 'https://scholar.google.com/scholar_lookup?title=Venous+thromboembolism+associated+with+long‐term+use+of+central+venous+catheters+in+cancer+patients+&author=M+Verso&author=G+Agnelli&publication_year=2003&hl=en']",14512399,https://doi.org/10.1200/JCO.2003.08.008, Verso 2003 ,additional,CD006468-bbs2-0121,
CD006468-bib-0172,"Akl EA, Kamath G, Schünemann H, Barba M, Kim YS, Yosuico VED, et al. ",Anticoagulation for thrombosis prophylaxis in cancer patients with central venous lines, Cochrane Database of Systematic Reviews ,2007,,    ,['citation-journal']," Akl EA, Kamath G, Schünemann H, Barba M, Kim YS, Yosuico VED, et al. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous lines.  Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD006468]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Anticoagulation+for+thrombosis+prophylaxis+in+cancer+patients+with+central+venous+lines+&author=EA+Akl&author=G+Kamath&author=H+Schünemann&author=M+Barba&author=YS+Kim&author=VED+Yosuico&publication_year=2007&hl=en'],,, Akl 2007a ,other_versions,CD006468-bbs2-0122,
CD006468-bib-0173,"Akl EA, Kamath G, Yosuico VE, Kim SY, Barba M, Sperati F, et al. ",Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters, Cochrane Database of Systematic Reviews ,2007,,    ,['citation-journal']," Akl EA, Kamath G, Yosuico VE, Kim SY, Barba M, Sperati F, et al. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters.  Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD006468.pub2]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Anticoagulation+for+thrombosis+prophylaxis+in+cancer+patients+with+central+venous+catheters+&author=EA+Akl&author=G+Kamath&author=VE+Yosuico&author=SY+Kim&author=M+Barba&author=F+Sperati&publication_year=2007&hl=en'],,, Akl 2007b ,other_versions,CD006468-bbs2-0123,
CD006468-bib-0174,"Akl EA, Vasireddi SR, Gunukula S, Yosuico VE, Barba M, Sperati F, et al. ",Anticoagulation for patients with cancer and central venous catheters, Cochrane Database of Systematic Reviews ,2011,,    ,['citation-journal']," Akl EA, Vasireddi SR, Gunukula S, Yosuico VE, Barba M, Sperati F, et al. Anticoagulation for patients with cancer and central venous catheters.  Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/14651858.CD006468.pub3]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Anticoagulation+for+patients+with+cancer+and+central+venous+catheters&author=EA+Akl&author=SR+Vasireddi&author=S+Gunukula&author=VE+Yosuico&author=M+Barba&author=F+Sperati&publication_year=2011&hl=en'],,, Akl 2011a ,other_versions,CD006468-bbs2-0124,
CD006468-bib-0175,"Akl EA, Vasireddi SR, Gunukula S, Yosuico VE, Barba M, Sperati F, et al. ",Anticoagulation for patients with cancer and central venous catheters, Cochrane Database of Systematic Reviews ,2011,,    ,['citation-journal']," Akl EA, Vasireddi SR, Gunukula S, Yosuico VE, Barba M, Sperati F, et al. Anticoagulation for patients with cancer and central venous catheters.  Cochrane Database of Systematic Reviews 2011, Issue 4. [DOI: 10.1002/14651858.CD006468.pub4]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Anticoagulation+for+patients+with+cancer+and+central+venous+catheters&author=EA+Akl&author=SR+Vasireddi&author=S+Gunukula&author=VE+Yosuico&author=M+Barba&author=F+Sperati&publication_year=2011&hl=en'],,, Akl 2011b ,other_versions,CD006468-bbs2-0125,
CD006468-bib-0176,"Akl EA, Ramly EP, Kahale LA, Yosuico VE, Barba M, Sperati F, et al. ",Anticoagulation for people with cancer and central venous catheters, Cochrane Database of Systematic Reviews ,2014,,    ,['citation-journal']," Akl EA, Ramly EP, Kahale LA, Yosuico VE, Barba M, Sperati F, et al. Anticoagulation for people with cancer and central venous catheters.  Cochrane Database of Systematic Reviews 2014, Issue 10. [DOI: 10.1002/14651858.CD006468.pub5]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD006468.pub5', 'https://scholar.google.com/scholar_lookup?title=Anticoagulation+for+people+with+cancer+and+central+venous+catheters&author=EA+Akl&author=EP+Ramly&author=LA+Kahale&author=VE+Yosuico&author=M+Barba&author=F+Sperati&publication_year=2014&hl=en']",,https://doi.org/10.1002/14651858.CD006468.pub5, Akl 2014 ,other_versions,CD006468-bbs2-0126,
